<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Medicine-4) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Night PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 74887,
    "choices": [
      {
        "id": 298445,
        "text": "<p><span style=\"font-size:16px;\">a and c</span></p>"
      },
      {
        "id": 298446,
        "text": "<p><span style=\"font-size:16px;\">c only</span></p>"
      },
      {
        "id": 298447,
        "text": "<p><span style=\"font-size:16px;\">a, b and d</span></p>"
      },
      {
        "id": 298448,
        "text": "<p><span style=\"font-size:16px;\">b and c</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following vaccines is generally not recommended for individuals over 65 years of age? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:16px;\">Hepatitis B</span></li><li><span style=\"font-size:16px;\">Influenza</span></li><li><span style=\"font-size:16px;\">Human papillomavirus (HPV)</span></li><li><span style=\"font-size:16px;\">Pneumococcal</span></li></ol>",
    "unique_key": "Q7517102",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233205,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) c only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">HPV vaccine is not recommended for individuals over 65 years of age because it is only approved for use up to 45 years of age. The other vaccines mentioned can be safely and effectively administered to elderly individuals based on their risk factors and previous vaccination status.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>a. Hepatitis B vaccine:</strong> This is conditionally indicated in elderly individuals who have not previously received the vaccine and have risk factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>b. Influenza vaccine:</strong> This is strongly recommended annually for elderly individuals as they are at high risk for complications from influenza infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>d. Pneumococcal vaccine:</strong> This is a crucial vaccine for elderly individuals. The current recommendation in India is to give PCV13 followed by PPSV23 to provide comprehensive protection against pneumococcal infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The age-based restrictions for HPV vaccination (approved only up to age 45) and the core vaccines recommended for elderly individuals (pneumococcal, influenza, and conditional hepatitis B vaccination).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The only non-recommended vaccine in this list for those over 65 years is <strong>HPV</strong>, while pneumococcal, influenza, and hepatitis B vaccines may all be indicated based on individual risk factors and previous vaccination status.</span></p>",
    "correct_choice_id": 298446,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74876,
    "choices": [
      {
        "id": 298405,
        "text": "<p><span style=\"font-size:16px;\">Chest X-ray findings</span></p>"
      },
      {
        "id": 298406,
        "text": "<p><span style=\"font-size:16px;\">Raised Trop T level</span></p>"
      },
      {
        "id": 298407,
        "text": "<p><span style=\"font-size:16px;\">CCF</span></p>"
      },
      {
        "id": 298408,
        "text": "<p><span style=\"font-size:16px;\">Diastolic murmur</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Nadas criteria include all of the following except:&nbsp;(INICET NOV 2024)</span></p>",
    "unique_key": "Q4652029",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233195,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Raised Trop T level</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Nadas criteria, proposed by Hungarian cardiologist Dr. Alexander Nadas in the 1950s\u201360s, are used for diagnosing congenital heart disease. The criteria require at least one major and two minor criteria for diagnosis. Major criteria include systolic murmur grade 3-4/6, diastolic murmur, presence of congestive heart failure, and cyanosis. Minor criteria include grade 2/6 systolic murmur, abnormal S2, abnormal chest X-ray, abnormal ECG, and abnormal blood pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Nadas criteria are used for diagnosing congenital heart disease, which includes both major criteria (systolic murmur grade 3-4/6, diastolic murmur, CCF, cyanosis) and minor criteria (grade 2/6 systolic murmur, abnormal S2, abnormal X-ray, abnormal ECG, abnormal BP).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ke331nr.png\" width=\"760\" height=\"218\"></strong></span></p>",
    "correct_choice_id": 298406,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50964,
    "choices": [
      {
        "id": 203397,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson syndrome&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203398,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan syndrome&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203399,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conn&#39;s syndrome&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203400,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addison&#39;s disease&nbsp;</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman comes with complaints of hyperpigmentation of her palms after an adrenalectomy. She also has new onset vision deficits. What is the likely diagnosis? (</span></span>INICET Nov 2023)</p>",
    "unique_key": "Q4407979",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233189,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson syndrome</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson syndrome occurs in patients who have undergone bilateral adrenalectomy for Cushing&#39;s disease due to an ACTH-secreting pituitary adenoma. After the adrenalectomy, the absence of cortisol feedback leads to increased secretion of ACTH by the pituitary adenoma. This results in:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperpigmentation:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Due to elevated levels of ACTH and its precursor, which stimulates melanocytes.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vision deficits:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caused by the growth of the pituitary adenoma, which can compress the optic chiasma.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sheehan syndrome</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Caused by postpartum necrosis of the pituitary gland, leading to hypopituitarism. It presents with failure to lactate, amenorrhea, and hypothyroidism, but not with hyperpigmentation or vision deficits post-adrenalectomy.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Conn&#39;s syndrome:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperaldosteronism, characterized by hypertension, hypokalemia, and metabolic alkalosis. It does not cause hyperpigmentation or vision deficits.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Addison&#39;s disease:&nbsp;&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary adrenal insufficiency presenting with hyperpigmentation due to high ACTH, but it is not typically associated with vision deficits or occurring after adrenalectomy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson syndrome is characterized by hyperpigmentation and vision deficits following bilateral adrenalectomy for Cushing&#39;s disease, due to the growth of an ACTH-secreting pituitary adenoma.</span></span></span></span></p>",
    "correct_choice_id": 203397,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74908,
    "choices": [
      {
        "id": 298529,
        "text": "<p><span style=\"font-size:16px;\">Nuclear pattern; SLE</span></p>"
      },
      {
        "id": 298530,
        "text": "<p><span style=\"font-size:16px;\">Homogeneous pattern; SLE</span></p>"
      },
      {
        "id": 298531,
        "text": "<p><span style=\"font-size:16px;\">Speckled pattern; Systemic sclerosis</span></p>"
      },
      {
        "id": 298532,
        "text": "<p><span style=\"font-size:16px;\">Anti-centromere pattern; Systemic sclerosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A patient presented with recurrent Raynaud\u2019s phenomenon. She also complained of thickening of skin in the hands and difficulty in swallowing. What is the diagnosis and immunofluorescence pattern shown? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xOrfzxr.png\" width=\"383\" height=\"381\"></span></p>",
    "unique_key": "Q5245863",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233226,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Anti-centromere pattern; Systemic sclerosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The combination of Raynaud's phenomenon, skin thickening limited to hands (acral areas), and difficulty swallowing points to <strong>limited systemic sclerosis</strong> (formerly called CREST syndrome). The immunofluorescence image shows a characteristic <strong>centromeric pattern</strong> with discrete speckles corresponding to centromeres in dividing cells. Anti-centromere antibodies are specifically associated with <strong>limited systemic sclerosis</strong>, making this pattern diagnostic in this clinical context.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Nuclear pattern; SLE:</strong> Incorrect. The pattern shown is centromeric, not nuclear.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Homogeneous pattern; SLE</strong>: Incorrect. Homogeneous patterns are produced by anti-histone and anti-dsDNA antibodies, seen in SLE or drug-induced lupus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Speckled pattern; Systemic sclerosis:</strong> Incorrect. While speckled patterns can be seen in systemic sclerosis (particularly with anti-Scl-70 antibodies in diffuse disease), the image shows a <strong>centromeric</strong> pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Anti-centromere antibodies producing a centromeric immunofluorescence pattern are specifically associated with <strong>limited systemic sclerosis</strong>, particularly when presenting with Raynaud's phenomenon and acral skin thickening.</span></p>",
    "correct_choice_id": 298532,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74885,
    "choices": [
      {
        "id": 298437,
        "text": "<p><span style=\"font-size:16px;\">Fungal hyphae surrounded by lymphocytes</span></p>"
      },
      {
        "id": 298438,
        "text": "<p><span style=\"font-size:16px;\">Anthracosis pigment</span></p>"
      },
      {
        "id": 298439,
        "text": "<p><span style=\"font-size:16px;\">Necrotizing epithelioid granuloma</span></p>"
      },
      {
        "id": 298440,
        "text": "<p><span style=\"font-size:16px;\">Reactive hyperplasia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 30-year-old woman presents with weight loss, mediastinal lymphadenopathy, and pleural effusion. Her HRCT shows a \"tree-in-bud\" pattern, indicating lung consolidation and effusion. Analysis of pleural fluid reveals high adenosine deaminase (ADA) levels with a predominance of lymphocytes. What is the most likely finding on lymph node biopsy? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8738829",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233203,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Necrotizing epithelioid granuloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This is a classic presentation of tuberculosis (TB):</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">\"Tree-in-bud\" appearance on HRCT indicates endobronchial spread \u2014 a hallmark of active pulmonary TB.</span></li><li><span style=\"font-size:16px;\">Mediastinal lymphadenopathy and pleural effusion with lymphocyte predominance further support a tuberculous etiology.</span></li><li><span style=\"font-size:16px;\">High ADA (&gt;40 U/L) in pleural fluid is a strong indicator of TB pleuritis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">The most characteristic lymph node biopsy finding in TB is:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>Necrotizing (caseating) epithelioid granulomas</strong></span></li><li><span style=\"font-size:16px;\">&nbsp;Composed of epithelioid cells (from activated macrophages), Langhans giant cells, and central caseous necrosis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Fungal hyphae surrounded by lymphocytes:</strong> &nbsp;Seen in invasive fungal infections (e.g., aspergillosis, histoplasmosis), more common in immunocompromised individuals; not typically associated with high ADA.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Anthracosis pigment:</strong> Black carbon pigment in lungs/lymph nodes from pollution or smoking. Not pathological in itself and doesn\u2019t cause systemic symptoms or effusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Reactive hyperplasia:</strong> Seen in viral or nonspecific bacterial infections. No granulomas or caseation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In a young woman with systemic symptoms, tree-in-bud pattern, lymphocytic pleural effusion, and high ADA, TB is the most likely diagnosis. The hallmark histopathological finding is a necrotizing epithelioid granuloma.</span></p>",
    "correct_choice_id": 298439,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74893,
    "choices": [
      {
        "id": 298469,
        "text": "<p><span style=\"font-size:16px;\">Target SpO\u2082 more than 94%</span></p>"
      },
      {
        "id": 298470,
        "text": "<p><span style=\"font-size:16px;\">Initiate targeted temperature management of &lt;33\u00b0C, if the patient is confused</span></p>"
      },
      {
        "id": 298471,
        "text": "<p><span style=\"font-size:16px;\">Perform emergent cardiac intervention if ST elevation is present in the ECG</span></p>"
      },
      {
        "id": 298472,
        "text": "<p><span style=\"font-size:16px;\">Maintain a mean arterial pressure (MAP) above 65 mmHg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following statements is incorrect regarding the management of patients who have achieved return of spontaneous circulation following CPR? (INICET NOV 2024)</span></p>",
    "unique_key": "Q7710676",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233211,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Initiate targeted temperature management of &lt;33\u00b0C, if the patient is confused</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In post-resuscitation care after return of spontaneous circulation (ROSC), targeted temperature management (TTM) should be maintained between 33\u201336\u00b0C, not below 33\u00b0C. Lower temperatures increase the risk of coagulopathy, bleeding, and infections like pneumonia. For patients with high bleeding risk or coagulopathy, the target should be 36\u201337.5\u00b0C.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Target SpO\u2082 &gt;94%:</strong> Initially, target SpO\u2082 should be &gt;92%, and once intubated and on mechanical ventilation, the target should be &gt;94%. Overall target range is 92\u201398%.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Perform emergent cardiac intervention if ST elevation is present in the ECG:</strong> If STEMI is identified as the cause of cardiac arrest, immediate cardiac catheterization should be performed within 2 hours as it's a reversible cause.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Maintain a mean arterial pressure (MAP) above 65 mmHg:</strong> This is the minimum MAP that should be achieved using vasopressors and IV fluids. The ideal MAP range is 80\u2013100 mmHg.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In post-resuscitation care after ROSC, targeted temperature management should be maintained between 33\u201336\u00b0C, with higher targets (36\u201337.5\u00b0C) for patients at risk of bleeding or coagulopathy. Temperature should never be targeted below 33\u00b0C due to increased complications.</span></p>",
    "correct_choice_id": 298470,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74878,
    "choices": [
      {
        "id": 298413,
        "text": "<p><span style=\"font-size:16px;\">Enthesitis</span></p>"
      },
      {
        "id": 298414,
        "text": "<p><span style=\"font-size:16px;\">Presence of diarrhea</span></p>"
      },
      {
        "id": 298415,
        "text": "<p><span style=\"font-size:16px;\">Dactylitis</span></p>"
      },
      {
        "id": 298416,
        "text": "<p><span style=\"font-size:16px;\">Nail pitting</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following cannot be used to differentiate psoriatic arthritis from other conditions? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2886435",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233197,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Presence of diarrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diarrhea cannot reliably differentiate psoriatic arthritis from other forms of arthritis because it can be present in multiple arthritic conditions. Diarrhea could indicate:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Reactive arthritis following gastrointestinal infection</span></li><li><span style=\"font-size:16px;\">Inflammatory bowel disease-associated arthritis</span></li><li><span style=\"font-size:16px;\">Post-viral arthritis</span></li><li><span style=\"font-size:16px;\">Other forms of seronegative spondyloarthropathies</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Enthesitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Enthesitis (inflammation at sites where tendons/ligaments insert into bone) is a characteristic feature of psoriatic arthritis</span></li><li><span style=\"font-size:16px;\">It helps differentiate psoriatic arthritis from other forms like rheumatoid arthritis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Dactylitis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Dactylitis (\"sausage digits\") is highly characteristic of psoriatic arthritis</span></li><li><span style=\"font-size:16px;\">Represents inflammation of the entire digit with soft tissue swelling</span></li><li><span style=\"font-size:16px;\">Helps differentiate from other forms where dactylitis is uncommon</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Nail pitting:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Nail changes are seen in 80\u201390% of psoriatic arthritis patients</span></li><li><span style=\"font-size:16px;\">Nail pitting is a characteristic finding that helps distinguish psoriatic arthritis</span></li><li><span style=\"font-size:16px;\">A valuable diagnostic feature when present</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Enthesitis, dactylitis, and nail changes are characteristic features that help diagnose psoriatic arthritis. Diarrhea is a nonspecific symptom that can occur in multiple forms of arthritis and cannot be used as a differentiating feature.</span></p>",
    "correct_choice_id": 298414,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74892,
    "choices": [
      {
        "id": 298465,
        "text": "<p><span style=\"font-size:16px;\">BP should be checked multiple times before administering anti-hypertensives</span></p>"
      },
      {
        "id": 298466,
        "text": "<p><span style=\"font-size:16px;\">In haemorrhagic stroke, you should aggressively treat with intravenous anti-hypertensives</span></p>"
      },
      {
        "id": 298467,
        "text": "<p><span style=\"font-size:16px;\">In haemorrhagic stroke, BP should be reduced to 160/100 mmHg with anti-hypertensives</span></p>"
      },
      {
        "id": 298468,
        "text": "<p><span style=\"font-size:16px;\">BP should be reduced immediately to less than 140/90 mmHg in ischemic stroke</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A patient presented with altered sensorium and his BP was 220/110 mmHg. He also had one episode of vomiting and on examination has weakness in the left upper and lower limbs. Which of the following is incorrect? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2429813",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233210,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) BP should be reduced immediately to less than 140/90 mmHg in ischemic stroke</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In acute ischemic stroke, blood pressure is often elevated as a physiological response to maintain perfusion to the ischemic penumbra. Unless:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The patient is receiving thrombolysis, in which case BP should be &lt;185/110 mmHg, or</span></li><li><span style=\"font-size:16px;\">The BP is severely elevated (&gt;220/120 mmHg),</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">You should not acutely lower the blood pressure. Lowering it to &lt;140/90 mmHg immediately is contraindicated, as it can worsen cerebral hypoperfusion and enlarge the infarct.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. BP should be checked multiple times before administering anti-hypertensives:&nbsp;</strong>Correct. Rechecking BP ensures accuracy and avoids overtreatment of transient spikes. Stroke protocols depend on consistently high values.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. In haemorrhagic stroke, you should aggressively treat with intravenous anti-hypertensives:&nbsp;</strong>Correct. Rapid BP control reduces ongoing bleeding and hematoma expansion. Agents like labetalol and nicardipine are preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. In haemorrhagic stroke, BP should be reduced to 160/100 mmHg with anti-hypertensives:&nbsp;</strong>Correct. Target BP of &lt;160/100 mmHg is generally accepted to balance the risk of further bleeding with maintaining cerebral perfusion. Even though it is not a specific recommendation in haemorrhagic stroke, it is acceptable.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Trials that are important \u2013</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_xvR4CKZ.png\" width=\"1191\" height=\"273\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The specific blood pressure targets in acute stroke:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">General recommendation in hypertensive emergency: Reduce BP by 25% in 1st hour, then target around 160/100 mmHg within 2\u20136 hours</span></li><li><span style=\"font-size:16px;\">Ischemic stroke with thrombolysis: &lt;185/110 mmHg</span></li><li><span style=\"font-size:16px;\">Ischemic stroke without thrombolysis: &lt;220/120 mmHg</span></li><li><span style=\"font-size:16px;\">Hemorrhagic Stroke: Controversial \u2013 SBP &lt;140 mmHg (INTERACT2) vs. 140\u2013180 mmHg (WHO 2021)</span></li></ul>",
    "correct_choice_id": 298468,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11349,
    "choices": [
      {
        "id": 45362,
        "text": "<p><span style=\"font-size:12.0pt;\">Heparin</span></p>"
      },
      {
        "id": 45363,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
      },
      {
        "id": 45364,
        "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
      },
      {
        "id": 45365,
        "text": "<p><span style=\"font-size:12.0pt;\">DC shock</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 72-year-old man with a history of HTN, DM2, and DLP is brought to the ER because of reports of palpitations and dizziness. ECG is ordered and shown in the image. His temperature is 36.8\u00b0C, PR is 106/min, RR is 18/min, BP is 84/46 mm Hg, and SpO2 is 92% on room air. What is the next step? (Neet pg 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191511.jpg\" alt=\"\" width=\"500\" height=\"285\"></p>",
    "unique_key": "Q1748193",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233372,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D. DC shock</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms of palpitations and dizziness and is found to have an irregularly irregular rhythm on ECG, consistent with <strong>atrial fibrillation (AF).</strong> The absence of distinct P waves and the presence of fibrillatory waves further support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's vital signs reveal a blood pressure of 84/46 mm Hg, indicating hemodynamic instability. In cases of tachyarrhythmias such as AF, the management approach depends on the patient's hemodynamic status. For patients who are hemodynamically unstable, immediate intervention is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Synchronized DC cardioversion</strong> is the treatment of choice in hemodynamically unstable patients with AF. This procedure involves delivering a synchronized shock to restore normal rhythm. The shock is timed (synchronized) to occur at the peak of the R wave to avoid inducing ventricular fibrillation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Specific contraindications for using synchronized direct current (DC) cardioversion (synchronized DC shocking) are <strong>sinus tachycardia, multifocal atrial tachycardia digoxin toxicity. But&nbsp;</strong>in cases where a patient is unstable and experiencing shock, immediate cardioversion is necessary despite these contraindications, underscoring the urgency in treating life-threatening arrhythmias in acute settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A.</strong> <strong>Heparin</strong>: Heparin is an anticoagulant used to prevent thromboembolic events in patients with AF. However, it is not the immediate intervention of choice for hemodynamically unstable patients. The priority in such cases is to stabilize the patient's condition, which requires electrical cardioversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B.</strong> <strong>Beta blocker</strong>: Beta blockers are used to control the heart rate in AF. They are not appropriate for initial management in an unstable patient, as they do not address the immediate need to restore a stable rhythm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Amiodarone</strong>: Amiodarone is an antiarrhythmic that can be used in the management of AF. However, it is typically used in stable patients or after electrical cardioversion has been attempted. In an unstable patient, immediate electrical cardioversion is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hemodynamically unstable patients with atrial fibrillation, immediate synchronized DC cardioversion is the next step to restore a stable rhythm and improve hemodynamic status.</span></p>",
    "correct_choice_id": 45365,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74906,
    "choices": [
      {
        "id": 298521,
        "text": "<p><span style=\"font-size:16px;\">Decreased action of LPL and increased action of HSL</span></p>"
      },
      {
        "id": 298522,
        "text": "<p><span style=\"font-size:16px;\">Increased action of LPL and increased action of HSL</span></p>"
      },
      {
        "id": 298523,
        "text": "<p><span style=\"font-size:16px;\">Decreased action of LPL and decreased action of HSL</span></p>"
      },
      {
        "id": 298524,
        "text": "<p><span style=\"font-size:16px;\">Increased action of LPL and decreased action of HSL</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">In a patient with diabetes mellitus, the synthesis of TG and VLDL is increased from the liver. What is the cause of the same? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8475908",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233224,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Decreased action of LPL and increased action of HSL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In diabetes mellitus, insulin deficiency or resistance leads to two important enzymatic changes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Decreased activity of Lipoprotein Lipase (LPL)</strong> \u2013 This enzyme normally converts triglycerides in blood to free fatty acids for storage in adipose tissue</span></li><li><span style=\"font-size:16px;\"><strong>Increased activity of Hormone Sensitive Lipase (HSL)</strong> \u2013 This promotes release of stored triglycerides as free fatty acids from adipose tissue</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">These changes result in:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Increased triglycerides in blood due to decreased LPL activity</span></li><li><span style=\"font-size:16px;\">Increased lipolysis and ketosis due to increased HSL activity</span></li><li><span style=\"font-size:16px;\">Overall increase in circulating free fatty acids</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Increased action of LPL and increased action of HSL:</strong> Insulin resistance/deficiency <strong>decreases</strong> LPL activity</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Decreased action of LPL and decreased action of HSL:</strong> HSL activity is <strong>increased</strong>, not decreased in diabetes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Increased action of LPL and decreased action of HSL:</strong> This would increase TG clearance and decrease lipolysis, opposite to what occurs in diabetes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In diabetes mellitus, decreased LPL and increased HSL activities lead to increased triglycerides and VLDL synthesis in the liver, contributing to diabetic dyslipidemia.</span></p>",
    "correct_choice_id": 298521,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11351,
    "choices": [
      {
        "id": 45370,
        "text": "<p><span style=\"font-size:12.0pt;\">STEMI</span></p>"
      },
      {
        "id": 45371,
        "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
      },
      {
        "id": 45372,
        "text": "<p><span style=\"font-size:12.0pt;\">Stable Angina</span></p>"
      },
      {
        "id": 45373,
        "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 74-year-old man with a history of dyslipidemia, hypertension, and aortic sclerosis presents to the emergency department with chest pain. He took 3 NTG tablets with no relief. His vitals are stable and cardiac enzymes were normal. An ECG on admission is shown. What is the likely diagnosis? (Neet pg 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191548.jpg\" alt=\"\" width=\"500\" height=\"268\"></p>",
    "unique_key": "Q4369885",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233374,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Unstable Angina</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">The patient's presentation includes chest pain unrelieved by nitroglycerin (NTG), stable vitals, and normal cardiac enzymes. The provided ECG is normal, showing no signs of ST elevation or ischemic changes such as ST depression or T wave inversion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Unstable Angina</strong> involves chest pain at rest or with minimal exertion, and normal cardiac enzymes. The patient has multiple risk factors (dyslipidemia, hypertension, aortic sclerosis), and the fact that his chest pain did not respond to NTG and his enzymes are normal strongly suggests unstable angina.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. STEMI: </strong>STEMI is characterized by ST elevation on ECG and elevated cardiac enzymes indicating myocardial necrosis. This patient's ECG shows no ST elevation, and his cardiac enzymes are normal, making STEMI unlikely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. NSTEMI: </strong>NSTEMI would present with elevated cardiac enzymes due to myocardial damage, despite the absence of ST elevation. This patient\u2019s normal enzyme levels exclude NSTEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Stable Angina: </strong>Stable angina presents with chest pain that is typically relieved by rest or nitroglycerin. The patient\u2019s chest pain persisted despite taking NTG, indicating that stable angina is not the correct diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Unstable angina is characterized by chest pain that occurs at rest or with minimal exertion, does not respond to nitroglycerin, and is associated with normal cardiac enzyme levels.</span></p>",
    "correct_choice_id": 45373,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74889,
    "choices": [
      {
        "id": 298453,
        "text": "<p><span style=\"font-size:16px;\">Plasmapheresis is not effective in refractory GBS</span></p>"
      },
      {
        "id": 298454,
        "text": "<p><span style=\"font-size:16px;\">IV immunoglobulins are the first line of treatment</span></p>"
      },
      {
        "id": 298455,
        "text": "<p><span style=\"font-size:16px;\">Areflexia in the weaker arm is included in diagnostic criteria</span></p>"
      },
      {
        "id": 298456,
        "text": "<p><span style=\"font-size:16px;\">Albumino-cytological dissociation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Regarding Guillain-Barr\u00e9 syndrome (GBS) in children, which of the following statements is false? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6128570",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233207,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Plasmapheresis is not effective in refractory GBS</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Plasmapheresis (plasma exchange, PEX) is a well-established and effective treatment in GBS, including in refractory or severe cases. It is considered equivalent in efficacy to IVIG and may be used in patients not responding to IVIG (controversial, and sequential administration of PEX after IVIG is not recommended, but some clinicians try on a case-by-case basis), or if IVIG is contraindicated or unavailable.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. IV immunoglobulins are the first line of treatment:</strong> Correct. IVIG can be used as first-line treatment, having equal efficacy to plasma exchange in GBS management.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Areflexia in the weaker arm is included in diagnostic criteria:</strong> Correct. Areflexia in the weaker arm is a mandatory diagnostic criterion according to Brighton criteria. GBS is a demyelinating disease affecting large fibers that form the basis of reflex arcs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Albumino-cytological dissociation:</strong> Correct. It is a classic feature of GBS, with high protein in CSF but normal cell count (&lt;10 cells). Any cell count &gt;50 essentially rules out GBS.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Plasmapheresis and IVIG are effective treatment options for GBS, including refractory cases, with neither being superior to the other. Never use immunosuppression or steroids in acute GBS.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_vQdge7y.png\" width=\"1155\" height=\"629\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Level of diagnostic certainty in Brighton criteria for GBS</strong></span></p>",
    "correct_choice_id": 298453,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11350,
    "choices": [
      {
        "id": 45366,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flunarizine</span></span></p>"
      },
      {
        "id": 45367,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan</span></span></p>"
      },
      {
        "id": 45368,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></p>"
      },
      {
        "id": 45369,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q1883460",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233373,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&rsquo;s symptoms of unilateral headache accompanied by nausea, photophobia, and phonophobia are classic indicators of a migraine. Migraine is a common condition in young females and can be associated with other symptoms such as primary Raynaud&#39;s phenomenon.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the acute management of migraines</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Mild to moderate attacks &ndash; Paracetamol or NSAIDs like Ketorolac.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Moderate to severe attacks - Triptans are the drugs of choice. Other group of drugs are Ditans/ Gepants</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sumatriptan, <span style=\"background-color:white\"><span style=\"color:black\">Rizatriptan</span></span> a commonly used triptan, is a 5HT 1B/1D agonist which effectively alleviates migraine symptoms by causing vasoconstriction of the dilated blood vessels thought to be responsible for migraine pain. This action helps to reduce the headache and associated symptoms rapidly. - </span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">All of these drugs are contraindicated in the setting of pregnancy&nbsp;except paracetamol. Triptans are unsafe in vascular conditions</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ditans</span></strong><span style=\"font-size:12.0pt\"> (Ex.</span><span style=\"font-size:12.0pt\"> Lasmiditan) are 5-HT1F receptor agonists. Unlike triptans, they do not cause vasoconstriction, making them safer for patients with vascular conditions such as coronary artery disease or peripheral arterial disease. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Gepents</strong> are CGRP (calcitonin gene-related peptide) antagonists or blocker. Gepents, including rimegepant, atogepant, ubrogepant, and zabigipant, are effective in migraine management. These are oral medications and do not cause vasoconstriction, which also makes them suitable for patients with certain vascular conditions.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note - Dopamine Receptor Blockers</span></strong><span style=\"font-size:12.0pt\">: Prochlorperazine is mentioned as an example of this class. While not the focus of the discussion, dopamine receptor blockers are noted as effective in managing migraines.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Flunarizine:</strong> Flunarizine is a calcium channel blocker used primarily for the prophylactic (preventive) treatment of migraines, not for acute management. It helps in reducing the frequency of migraine attacks but does not relieve symptoms once an attack has started.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Propranolol:</span></strong><span style=\"font-size:12.0pt\"> Propranolol is a beta-blocker used for the prophylaxis of migraines. It is effective in reducing the frequency and severity of migraine attacks over time but is not used for immediate relief during an acute migraine episode.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Topiramate:</span></strong><span style=\"font-size:12.0pt\"> Topiramate is an anticonvulsant medication also used for the prophylactic treatment of migraines. Similar to propranolol, it helps prevent migraines but is not effective in treating acute migraine symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan is the drug of choice for the acute management of moderate to severe migraine attacks due to its vasoconstrictive properties and effectiveness in rapidly alleviating migraine symptoms.</span></span></p>",
    "correct_choice_id": 45367,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20267,
    "choices": [
      {
        "id": 81029,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated histoplasmosis</span></p>"
      },
      {
        "id": 81030,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV with disseminated cryptococcosis</span></p>"
      },
      {
        "id": 81031,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV with molluscum contagiosum</span></p>"
      },
      {
        "id": 81032,
        "text": "<p><span style=\"font-size:12.0pt;\">HIV with tuberculosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old HIV-positive male came with complaints of persistent cough and weight loss. He has skin lesions as shown in the image. Chest x-ray showed multiple bilateral nodular infiltrates. His sputum CBNAAT for tuberculosis was negative and he has a low CD4 count. What is the probable diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170533.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p>",
    "unique_key": "Q4719489",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233336,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. HIV with disseminated histoplasmosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the patient presents with persistent cough, weight loss, and skin lesions. The chest x-ray reveals multiple bilateral nodular infiltrates, and the patient has a low CD4 count. These findings are significant for several reasons:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Disseminated histoplasmosis</strong> can mimic tuberculosis, especially in HIV-positive patients. It causes disseminated disease with pulmonary involvement (multiple bilateral nodular infiltrates) and skin lesions. The presence of these lesions and a negative sputum CBNAAT for tuberculosis further supports histoplasmosis, as this fungal infection is common in immunocompromised individuals with low CD4 counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. HIV with disseminated cryptococcosis</strong>: While cryptococcosis can cause lung disease, it more commonly presents with central nervous system involvement, such as meningitis or meningoencephalitis. This patient does not exhibit neurological symptoms, making cryptococcosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. HIV with molluscum contagiosum</strong>: Molluscum contagiosum causes umbilicated papules but does not lead to bilateral nodular infiltrates in the lungs. Thus, this diagnosis is unlikely given the chest x-ray findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HIV with tuberculosis</strong>: Tuberculosis is a common infection in HIV-positive patients and can present with similar symptoms and radiographic findings. However, the negative sputum CBNAAT for tuberculosis makes this diagnosis less likely.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disseminated histoplasmosis in HIV-positive patients can mimic tuberculosis, presenting with pulmonary nodular infiltrates and skin lesions, especially in those with low CD4 counts.</span></p>",
    "correct_choice_id": 81029,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11354,
    "choices": [
      {
        "id": 45382,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis</span></span></span></p>"
      },
      {
        "id": 45383,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      },
      {
        "id": 45384,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lymphoma</span></span></span></p>"
      },
      {
        "id": 45385,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypersensitive pneumonitis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with fever, night sweats, ptosis, and bilateral facial nerve palsy. Investigations showed leukocytosis and bilateral hilar lymphadenopathy. Which of the following is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q4214208",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233377,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Sarcoidosis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with fever, night sweats, ptosis, and bilateral facial nerve palsy. The investigations show leukocytosis and bilateral hilar lymphadenopathy. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hilar lymphadenopathy can be seen in many conditions like Sarcoidosis, Pneumoconiosis, TB, etc</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">But the other clinical features point towards sarcoidosis, a systemic inflammatory disease characterized by non-caseating granulomas. Sarcoidosis can affect multiple organs, but it commonly involves the lungs and lymph nodes. Bilateral hilar lymphadenopathy is a hallmark finding in sarcoidosis and is often the first clue in diagnosis. Additionally, sarcoidosis can present with systemic symptoms like fever and night sweats.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of bilateral facial nerve palsy is another significant clue. While Guillain-Barre syndrome, Lyme disease, and sarcoidosis can cause bilateral lower motor neuron (LMN) type facial palsy, the combination of other symptoms and bilateral hilar lymphadenopathy strongly favors sarcoidosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Tuberculosis: </span></strong><span style=\"font-size:12.0pt\">Tuberculosis (TB) can present with fever, night sweats, and lymphadenopathy, including hilar lymphadenopathy. However, TB typically causes caseating granulomas and does not commonly present with bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Lymphoma</strong>: Lymphoma can also present with fever, night sweats, and lymphadenopathy. However, it typically involves systemic B symptoms and other lymph node groups. Bilateral facial nerve palsy is not a common presentation of lymphoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Hypersensitive pneumonitis</span></strong><span style=\"font-size:12.0pt\">: Hypersensitive pneumonitis can present with respiratory symptoms and lymphadenopathy, but it is usually associated with exposure to inhaled organic antigens. It does not typically cause systemic symptoms like fever, night sweats, and bilateral facial nerve palsy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilateral hilar lymphadenopathy with systemic symptoms like fever and night sweats and the presence of bilateral facial nerve palsy is highly suggestive of sarcoidosis. Always consider sarcoidosis first in such clinical scenarios.</span></span></p>",
    "correct_choice_id": 45382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52808,
    "choices": [
      {
        "id": 210721,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span></span></span></p>"
      },
      {
        "id": 210722,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poststreptococcal glomerulonephritis</span></span></span></p>"
      },
      {
        "id": 210723,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
      },
      {
        "id": 210724,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgA nephropathy</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman presents to you with fever, arthralgia, ulcers, fatigue for the past six months, and new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis? (NEET PG 2023)</span></span></span></p>",
    "unique_key": "Q3984765",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233365,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C. Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is a common complication of systemic lupus erythematosus (SLE), an autoimmune disease that can affect multiple organ systems. The patient&#39;s symptoms of fever, arthralgia, ulcers, and fatigue, combined with new-onset hematuria and findings of RBC casts and proteinuria in the urine, are indicative of systemic involvement typical of lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is characterized by inflammation of the kidneys, often leading to hematuria, proteinuria, and renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Next Step -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conducting an ANA (antinuclear antibody) test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing an anti-dsDNA (anti-double stranded DNA) test, which is noted as being very specific and correlates with lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute interstitial nephritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically presents with WBC casts rather than RBC casts in the urine and is not usually associated with systemic symptoms like fever, arthralgia, or ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Poststreptococcal glomerulonephritis (PSGN):</span></strong><span style=\"font-size:12.0pt\"> While PSGN can cause RBC casts and proteinuria, it is generally a renal-limited condition and does not present with systemic symptoms like fever, arthralgia, and ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. IgA nephropathy:</span></strong><span style=\"font-size:12.0pt\"> IgA nephropathy is also a renal-limited condition and typically does not present with systemic symptoms. It is characterized by recurrent episodes of gross hematuria, usually following upper respiratory infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis should be suspected in patients with systemic lupus erythematosus who present with renal symptoms such as hematuria and proteinuria, especially when accompanied by systemic symptoms like fever, arthralgia, ulcers, and fatigue. Further testing, including ANA and anti-dsDNA antibodies, is warranted to confirm the diagnosis.</span></span></p>",
    "correct_choice_id": 210723,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52810,
    "choices": [
      {
        "id": 210729,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Whole Bowel Irrigation</span></span></span></p>"
      },
      {
        "id": 210730,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Activated charcoal</span></span></span></p>"
      },
      {
        "id": 210731,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dimercaprol</span></span></span></p>"
      },
      {
        "id": 210732,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Penicillamine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A child presents to the emergency department with a history of ingestion of 10-20 ferrous sulfate tablets. Arterial blood gas revealed acidosis. Which of the following can be used in the management of this condition? (NEET PG 2023)</span></span></span></p>",
    "unique_key": "Q7478997",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233367,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Whole Bowel Irrigation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The child has ingested a significant amount of ferrous sulfate, leading to iron intoxication, which has resulted in metabolic acidosis. Managing iron overdose requires specific interventions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Points:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Iron Intoxication:</span></strong><span style=\"font-size:12.0pt\"> Iron overdose is a common pediatric poisoning that can lead to significant morbidity and mortality. Ingesting a large number of ferrous sulfate tablets can result in gastrointestinal irritation, systemic toxicity, and metabolic acidosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arterial Blood Gas (ABG) Revealed Acidosis:</span></strong><span style=\"font-size:12.0pt\"> Metabolic acidosis is a severe consequence of iron poisoning, indicating systemic toxicity.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Management of Iron Intoxication:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Whole Bowel Irrigation (WBI):</span></strong><span style=\"font-size:12.0pt\"> This is a key intervention for decontaminating the gastrointestinal tract in cases of iron overdose. WBI is performed using a polyethylene glycol-electrolyte solution to flush out the gastrointestinal contents. It is particularly useful <strong>when iron tablets are visible on an abdominal X-ray.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Antidote:</span></strong><span style=\"font-size:12.0pt\"> The specific antidote for iron poisoning is deferoxamine, which binds free iron and promotes its excretion. While deferoxamine is essential in managing iron toxicity, it is not listed as an option in this question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Activated Charcoal:</span></strong><span style=\"font-size:12.0pt\"> As mentioned, it is not effective for iron, alcohols, acids, alkalis, or petroleum product intoxications. Activated charcoal does not adsorb iron, making it unsuitable for treating iron overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dimercaprol:</span></strong><span style=\"font-size:12.0pt\"> Used for heavy metal poisoning like arsenic, gold, and mercury, but not effective for iron.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Penicillamine:</span></strong><span style=\"font-size:12.0pt\"> Used primarily for heavy metal poisoning like copper and lead, and ineffective for iron.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Whole Bowel Irrigation with polyethylene glycol is the preferred method for managing iron tablet ingestion, especially when iron tablets are visible on an abdominal X-ray.</span></strong></span></span></p>",
    "correct_choice_id": 210729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20264,
    "choices": [
      {
        "id": 81017,
        "text": "<p><span style=\"font-size:12.0pt;\">Flunarizine</span></p>"
      },
      {
        "id": 81018,
        "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
      },
      {
        "id": 81019,
        "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
      },
      {
        "id": 81020,
        "text": "<p><span style=\"font-size:12.0pt;\">Topiramate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management? (NEET PG 2023)</span></p>",
    "unique_key": "Q4176157",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233334,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms are characteristic of a migraine, which is often associated with unilateral headache, nausea, photophobia (sensitivity to light), and phonophobia (sensitivity to sound).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sumatriptan:</strong> This medication is a serotonin receptor agonist (triptan) used for the acute treatment of migraine attacks. It works by stimulating serotonin (5-HT) receptors in the brain, leading to vasoconstriction of dilated blood vessels and relief from migraine symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best drug for acute management of a migraine attack in this scenario is Sumatriptan.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Flunarizine:</strong> This is a calcium channel blocker used for the prophylactic treatment of migraine, not for acute management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Propranolol:</strong> This beta-blocker is also used for migraine prophylaxis, not for acute attacks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Topiramate:</strong> Used for preventing migraine, not for treating an acute attack.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educaitonal Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sumatriptan is the best medication for the acute management of migraine, characterized by unilateral headache, nausea, photophobia, and phonophobia.</span></p>",
    "correct_choice_id": 81018,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20268,
    "choices": [
      {
        "id": 81033,
        "text": "<p><span style=\"font-size:12.0pt;\">Extradural cord compression</span></p>"
      },
      {
        "id": 81034,
        "text": "<p><span style=\"font-size:12.0pt;\">Amyotrophic lateral sclerosis</span></p>"
      },
      {
        "id": 81035,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
      },
      {
        "id": 81036,
        "text": "<p><span style=\"font-size:12.0pt;\">Subacute combined degeneration of the cord</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A male patient presents with sensory loss and weakness of limbs for 3 months. He also has angular stomatitis. On examination, there is loss of proprioception, vibration sensations, UMN type of lower limb weakness, and absent ankle reflex. What is the most probable diagnosis? (NEET PG 2023)</span></p>",
    "unique_key": "Q7320906",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233337,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Subacute combined degeneration of the cord</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with sensory loss, limb weakness, and specific neurological findings that are indicative of subacute combined degeneration of the cord due to vitamin B12 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Findings:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Sensory Loss and Weakness of Limbs:</strong> This suggests a neurological disorder affecting the peripheral and central nervous systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Angular Stomatitis:</strong> This is often associated with vitamin deficiencies, particularly vitamin B12.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Loss of Proprioception and Vibration Sensation:</strong> This is characteristic of posterior column involvement, which is seen in subacute combined degeneration.</span></li><li><span style=\"font-size:12.0pt;\"><strong>UMN Type of Lower Limb Weakness:</strong> Upper motor neuron signs (UMN) such as spasticity and exaggerated reflexes, except for the absent ankle reflex, are indicative of corticospinal tract involvement.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Absent Ankle Reflex:</strong> This, along with UMN signs, is a classic feature of subacute combined degeneration of the cord.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Subacute Combined Degeneration of the Cord:</strong> This condition is due to vitamin B12 deficiency, leading to demyelination of the posterior columns and corticospinal tracts. This results in a combination of sensory ataxia, spasticity, and other upper motor neuron signs, except for the absent ankle reflex which indicates peripheral neuropathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Findings:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Angular Stomatitis:</strong> Points towards a vitamin deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Babinski Positivity with Absent Ankle Jerk:</strong> This combination is specifically associated with subacute combined degeneration of the cord due to B12 deficiency. Other conditions like cauda equina syndrome or Friedreich ataxia could present similarly, but the presence of angular stomatitis and the described neurological findings strongly support subacute combined degeneration.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Extradural Cord Compression:</strong> This would typically present with radicular pain and possibly more pronounced lower motor neuron signs below the level of compression, not the UMN signs described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amyotrophic Lateral Sclerosis (ALS):</strong> ALS involves both UMN and LMN signs but does not typically present with sensory loss or specific vitamin deficiency signs like angular stomatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Multiple Sclerosis (MS):</strong> MS can present with varied neurological signs, but it does not typically present with angular stomatitis or the classic combination of absent ankle reflex with UMN signs seen in subacute combined degeneration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Subacute combined degeneration of the cord due to vitamin B12 deficiency presents with sensory loss, UMN signs in the lower limbs, and absent ankle reflex, along with other signs of vitamin deficiency like angular stomatitis.</span></p>",
    "correct_choice_id": 81036,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11355,
    "choices": [
      {
        "id": 45386,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Consolidation</span></span></span></p>"
      },
      {
        "id": 45387,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mass</span></span></span></p>"
      },
      {
        "id": 45388,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pleural effusion</span></span></span></p>"
      },
      {
        "id": 45389,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diaphragmatic hernia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient presents to you with fever, breathlessness, and cough with expectoration. A CT scan was done which is shown below. What is the most likely diagnosis? (Neet pg 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191655.jpg\" style=\"height:253px; width:400px\" /></p>",
    "unique_key": "Q7104903",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233378,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Consolidation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s symptoms of fever, breathlessness, and cough with expectoration suggest an infectious process in the lungs. The CT scan provided shows a large area of increased density (whitish patch) in the right lung, particularly in the lower lobe. This area is accompanied by air bronchograms, which are dark branching structures representing air-filled bronchi within the consolidated lung tissue. The presence of air bronchograms is a classic sign of consolidation, which indicates that the alveoli are filled with inflammatory exudates, cells, or other materials, typically due to pneumonia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Mass:</strong> A mass would appear as a localized, well-defined lesion in the lung tissue without the characteristic air bronchograms seen in consolidation. It would not typically present with diffuse symptoms like those described (fever, breathlessness, and productive cough).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Pleural Effusion:</span></strong><span style=\"font-size:12.0pt\"> Pleural effusion involves the accumulation of fluid in the pleural space surrounding the lungs. On imaging, it appears as a homogenous opacity at the lung base with a meniscus sign. It does not show air bronchograms and typically does not present with the same radiographic features as consolidation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Diaphragmatic Hernia:</span></strong><span style=\"font-size:12.0pt\"> A diaphragmatic hernia involves the protrusion of abdominal contents into the thoracic cavity through a defect in the diaphragm. This condition would appear on imaging as abdominal organs (e.g., intestines) within the chest cavity, not as a consolidation pattern with air bronchograms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Consolidation in the lung, often due to pneumonia, is characterized by a homogenous area of increased density with air bronchograms on imaging, and presents with symptoms such as fever, breathlessness, and productive cough.</span></span></p>",
    "correct_choice_id": 45386,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20258,
    "choices": [
      {
        "id": 80993,
        "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
      },
      {
        "id": 80994,
        "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
      },
      {
        "id": 80995,
        "text": "<p><span style=\"font-size:12.0pt;\">Esmolol</span></p>"
      },
      {
        "id": 80996,
        "text": "<p><span style=\"font-size:12.0pt;\">Propylthiouracil</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents with severe restlessness, palpitations, and tremors to the emergency department. She is a known case of bronchial asthma. On examination, the neck looks swollen. Blood pressure is elevated, and tachycardia is noted. ECG shows atrial fibrillation. Which of the following drugs is used for immediate management in this patient? (NEET PG 2023)</span></p>",
    "unique_key": "Q1754187",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233331,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Diltiazem</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient with atrial fibrillation and bronchial asthma, the primary goal is to control the heart rate. For rate control in atrial fibrillation, beta-blockers and non-dihydropyridine calcium channel blockers (NDCCBs) like diltiazem or verapamil are commonly used. However, in this case, the patient has bronchial asthma, which makes the use of beta-blockers (such as propranolol and esmolol) less suitable due to their potential to exacerbate asthma symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diltiazem is a non-dihydropyridine calcium channel blocker that effectively controls the heart rate without affecting bronchial muscle tone, making it a safer option for patients with asthma. Therefore, diltiazem is the drug of choice for immediate management in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Propranolol:</strong> Propranolol is a beta-blocker, which can exacerbate bronchial asthma by causing bronchoconstriction. Thus, it is not a suitable choice for patients with asthma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Esmolol:</strong> Similar to propranolol, esmolol is a beta-blocker and can worsen asthma symptoms due to its bronchoconstrictive effects, making it unsuitable for this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Propylthiouracil:</strong> This medication is used in the management of thyroid storm, a condition associated with severe hyperthyroidism. It is not relevant for rate control in atrial fibrillation and does not address the immediate needs of this patient's condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For immediate rate control in atrial fibrillation in a patient with bronchial asthma, non-dihydropyridine calcium channel blockers like diltiazem are preferred over beta-blockers to avoid exacerbating asthma symptoms.</span></p>",
    "correct_choice_id": 80993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11348,
    "choices": [
      {
        "id": 45358,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD4+ T cell count</span></span></span></p>"
      },
      {
        "id": 45359,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load</span></span></span></p>"
      },
      {
        "id": 45360,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">p24 antigen</span></span></span></p>"
      },
      {
        "id": 45361,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral serotype</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with retro-positive status was started on 2nd line highly active antiretroviral therapy (HAART). Which of the following can be used to monitor treatment efficacy? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q8938833",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233371,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Viral load</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the primary method used to monitor the efficacy of antiretroviral therapy (ART) in patients with HIV. According to WHO and NACO guidelines, the monitoring of viral load is crucial for assessing the effectiveness of the treatment. Initially, viral load is <strong>monitored every six months until the regimen is stabilized</strong>. <strong>After that, it is monitored annually.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The goal of ART is to achieve an undetectable viral load, defined as <strong>less than 50 copies per mL</strong>. If the viral load is less than 50 copies, it indicates effective suppression of the virus, and the patient can continue with the same ART regimen with yearly monitoring. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">If the viral load exceeds 1000 copies, it suggests treatment failure</span></strong><span style=\"font-size:12.0pt\">, necessitating a change in the ART regimen. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">For viral loads between 50 and 1000 copies, the issue is often due to poor adherence to therapy,&nbsp;</span></strong><span style=\"font-size:12.0pt\">and it is recommended to ensure adherence and frequently <strong>monitor viral load every three months</strong> until suppression is achieved.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>CD4+ T cell count</strong>: Previously, CD4+ T cell count was commonly used to monitor HIV treatment. However, current guidelines prioritize viral load over CD4 count for monitoring treatment efficacy. While CD4 count is still important for assessing the immune system&#39;s health, it is not the primary marker for treatment efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>p24 antigen</strong>: The p24 antigen is a protein associated with HIV. It is used for early detection of HIV infection but is not suitable for monitoring long-term treatment efficacy. p24 levels do not provide reliable information on viral suppression or ART effectiveness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Viral serotype</strong>: Viral serotyping involves identifying different strains of HIV but does not provide information on treatment efficacy. It is more relevant in epidemiological studies and vaccine development rather than in monitoring ongoing therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Viral load measurement is the most important and recommended method for monitoring the efficacy of antiretroviral therapy in HIV patients. The goal is to achieve an undetectable viral load (&lt;50 copies/mL).</span></span></span></p>",
    "correct_choice_id": 45359,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74897,
    "choices": [
      {
        "id": 298485,
        "text": "<p><span style=\"font-size:16px;\">Pathergy test is a criterion as per the ISG diagnostic criteria</span></p>"
      },
      {
        "id": 298486,
        "text": "<p><span style=\"font-size:16px;\">Ulcers are common on the dorsum of the penis</span></p>"
      },
      {
        "id": 298487,
        "text": "<p><span style=\"font-size:16px;\">Aphthous ulcers occur similar to Crohn\u2019s disease</span></p>"
      },
      {
        "id": 298488,
        "text": "<p><span style=\"font-size:16px;\">Bilateral pan uveitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not correct regarding Beh\u00e7et's disease? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1110942",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233215,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Ulcers are common on the dorsum of the penis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Beh\u00e7et's disease is a chronic, multisystem vasculitis characterized by recurrent oral and genital ulcers, ocular inflammation, skin lesions, and more. Genital ulcers in Beh\u00e7et's typically occur on the scrotum in males and the vulva in females. The dorsum of the penis is rarely involved.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pathergy test is a criterion as per the ISG diagnostic criteria:</strong> Correct. The International Study Group (ISG) includes the pathergy test (a sterile pustule at the site of needle prick) as a supportive criterion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Aphthous ulcers occur similar to Crohn\u2019s disease:</strong> Correct. The oral ulcers of Beh\u00e7et\u2019s resemble aphthous ulcers and can be clinically indistinguishable from those seen in Crohn\u2019s disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;D. Bilateral pan uveitis:&nbsp;</strong>Correct. Ocular involvement is common and may present as anterior uveitis, posterior uveitis, or pan uveitis\u2014often bilateral and sight-threatening.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Beh\u00e7et\u2019s disease typically affects the scrotum, vulva, eyes, and oral mucosa. Ulcers on the dorsum of the penis are atypical, making option B the incorrect statement.</span></p>",
    "correct_choice_id": 298486,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74881,
    "choices": [
      {
        "id": 298425,
        "text": "<p><span style=\"font-size:16px;\">Brugada syndrome</span></p>"
      },
      {
        "id": 298426,
        "text": "<p><span style=\"font-size:16px;\">Uhl anomaly</span></p>"
      },
      {
        "id": 298427,
        "text": "<p><span style=\"font-size:16px;\">Hypertrophic obstructive cardiomyopathy</span></p>"
      },
      {
        "id": 298428,
        "text": "<p><span style=\"font-size:16px;\">Arrhythmogenic right ventricular dysplasia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 25-year-old woman reports episodes of palpitations and dizziness, particularly following physical activity such as playing tennis. She has experienced these symptoms multiple times over the last two years. ECG is taken and it is shown. Based on her presentation and the accompanying ECG findings, which of the following diagnoses is most likely? (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cS5E9cv.png\" width=\"718\" height=\"300\"></span></p>",
    "unique_key": "Q5574740",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233200,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Arrhythmogenic right ventricular dysplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The diagnosis of Arrhythmogenic Right Ventricular Dysplasia (ARVD) is based on:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">A young patient with exertional palpitations and dizziness</span></li><li><span style=\"font-size:16px;\">ECG shows characteristic epsilon waves\u2014multiple wavelet-like appearances at the J point</span></li><li><span style=\"font-size:16px;\">T-wave inversions in V1\u2013V4 indicating RV strain/dysfunction</span></li><li><span style=\"font-size:16px;\">This condition involves fibro-fatty replacement of right ventricular myocardium in the \"triangle of dysplasia\"</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Brugada syndrome:</strong> Incorrect. It typically causes arrhythmias during rest, not exertion. ECG shows characteristic ST elevation with \"coved\" appearance in V1\u2013V3, not epsilon waves.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Uhl anomaly:</strong> Incorrect. It involves congenital absence of right ventricular musculature, which doesn't match the ECG findings or clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Hypertrophic obstructive cardiomyopathy:</strong> Incorrect. ECG would show LVH with Sokolov-Lyon criteria (S in V1 + R in V5/V6 &gt; 35mm) and septal Q waves in lateral leads.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Epsilon waves on ECG are pathognomonic for ARVD, which typically presents in young people with exertional symptoms and can be a cause of sudden cardiac death, particularly common in Italy. The condition involves desmosomal mutations and progressive RV dysfunction.</span></p>",
    "correct_choice_id": 298428,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74904,
    "choices": [
      {
        "id": 298513,
        "text": "<p><span style=\"font-size:16px;\">Nevi</span></p>"
      },
      {
        "id": 298514,
        "text": "<p><span style=\"font-size:16px;\">Atrial myxoma</span></p>"
      },
      {
        "id": 298515,
        "text": "<p><span style=\"font-size:16px;\">Myxoid neurofibroma</span></p>"
      },
      {
        "id": 298516,
        "text": "<p><span style=\"font-size:16px;\">Ebstein's anomaly</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not a component of NAME syndrome? (INICET NOV 2024)</span></p>",
    "unique_key": "Q3961729",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233222,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Ebstein's anomaly</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">NAME syndrome is now recognized as part of the Carney complex, which falls under Multiple Endocrine Other Organ Neoplasia (MEON). The NAME acronym stands for:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">N: Nevi (blue nevi \u2013 skin manifestation)</span></li><li><span style=\"font-size:16px;\">A: Atrial myxoma</span></li><li><span style=\"font-size:16px;\">M: Myxoid neurofibroma</span></li><li><span style=\"font-size:16px;\">E: Ephelides (freckles)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ebstein's anomaly is not a component of this syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:16px;\">NAME syndrome (now part of Carney complex) consists of Nevi (blue), Atrial myxoma, Myxoid neurofibroma, and Ephelides (freckles). Ebstein's anomaly is not a component of this syndrome.</span></p>",
    "correct_choice_id": 298516,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20265,
    "choices": [
      {
        "id": 81021,
        "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
      },
      {
        "id": 81022,
        "text": "<p><span style=\"font-size:12.0pt;\">Kaposi sarcoma</span></p>"
      },
      {
        "id": 81023,
        "text": "<p><span style=\"font-size:12.0pt;\">Malignant melanoma</span></p>"
      },
      {
        "id": 81024,
        "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old HIV patient presented with a painful lesion, as shown in the image. What is the most likely diagnosis? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170516.jpg\" alt=\"\" width=\"300\" height=\"303\"></span></p>",
    "unique_key": "Q6522920",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233335,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Kaposi sarcoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma (KS) is a common malignancy in patients with HIV/AIDS. It is caused by human herpesvirus 8 (HHV-8) and typically presents as painless or painful, violaceous (purple) lesions on the skin and mucous membranes, including the oral cavity. The image shows such a lesion on the palate, which is characteristic of Kaposi sarcoma. These lesions are vascular in nature and can vary in color from red to purple, often with a raised or nodular appearance. In HIV patients, Kaposi sarcoma is an AIDS-defining condition and is often seen in those with significant immunosuppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Basal cell carcinoma:</strong> This type of skin cancer usually occurs in sun-exposed areas of the skin and rarely affects mucous membranes. It typically presents as a pearly or waxy bump, not as multiple purple lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Malignant melanoma:</strong> While melanomas can appear as pigmented lesions, they are usually black or brown and rarely present as multiple violaceous lesions in the oral cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Squamous cell carcinoma:</strong> This type of cancer can occur in the oral cavity but usually presents as a non-healing ulcer or a raised, firm, scaly plaque. It does not have the characteristic color and appearance of Kaposi sarcoma lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kaposi sarcoma should be suspected in HIV patients presenting with violaceous lesions on the skin or mucous membranes. It is an AIDS-defining condition associated with HHV-8 infection.</span></p>",
    "correct_choice_id": 81022,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20269,
    "choices": [
      {
        "id": 81037,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral stenosis</span></p>"
      },
      {
        "id": 81038,
        "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid stenosis</span></p>"
      },
      {
        "id": 81039,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral regurgitation</span></p>"
      },
      {
        "id": 81040,
        "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old female patient came with complaints of chest pain, palpitation, and shortness of breath. On examination, a mid-diastolic murmur was heard, and a prominent 'a' wave was found on JVP. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
    "unique_key": "Q9216676",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233338,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. Tricuspid stenosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of a mid-diastolic murmur and a prominent 'a' wave in the jugular venous pressure (JVP) are key indicators for diagnosing tricuspid stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tricuspid Stenosis</strong> causes an obstruction to right ventricular inflow, which leads to an increase in right atrial pressure, reflected as a prominent 'a' wave in the JVP. The mid-diastolic murmur is due to the turbulent flow across the narrowed tricuspid valve during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitral Stenosis:</strong> While it can cause a diastolic murmur, it typically does not cause a prominent 'a' wave in the JVP unless there is secondary pulmonary hypertension affecting the right side of the heart.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Regurgitation:</strong> This would cause a holosystolic murmur and, if severe enough to cause pulmonary hypertension, may indirectly cause changes in the JVP, but it does not directly cause a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid Regurgitation:</strong> This condition causes a large 'v' wave in the JVP due to backflow of blood into the right atrium during systole, not a prominent 'a' wave.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A prominent 'a' wave in JVP and a mid-diastolic murmur are indicative of tricuspid stenosis, a condition causing right ventricular inflow obstruction.</span></p>",
    "correct_choice_id": 81038,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20273,
    "choices": [
      {
        "id": 81053,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumor</span></span></span></p>"
      },
      {
        "id": 81054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Upper lobe pneumonia</span></span></span></p>"
      },
      {
        "id": 81055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Superior vena cava obstruction</span></span></span></p>"
      },
      {
        "id": 81056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aspergilloma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old chronic smoker came to the medicine outpatient department with complaints of upper chest discomfort and drooping of an eyelid. He also complained of pain radiating to the upper arm and a tingling sensation in the 4th and 5th digits of his left hand. The chest X-ray is given below. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170545.jpg\" style=\"height:334px; width:300px\" /></span></span></span></p>",
    "unique_key": "Q6532495",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233363,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Pancoast tumor</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pancoast tumors, also known as superior sulcus tumors, are a type of lung cancer located at the apex (top) of the lung. These tumors are particularly associated with several key clinical features and findings, especially in chronic smokers:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Upper chest discomfort</span></strong><span style=\"font-size:12.0pt\">: This is a common symptom of a Pancoast tumor due to the tumor&#39;s location at the apex of the lung.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drooping of an eyelid (ptosis)</span></strong><span style=\"font-size:12.0pt\">: This is part of Horner&#39;s syndrome, which occurs due to compression of the sympathetic nerves by the tumor. Horner&#39;s syndrome typically includes ptosis (drooping eyelid), miosis (constricted pupil), and anhidrosis (lack of sweating) on the affected side of the face.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pain radiating to the upper arm and tingling sensation</span></strong><span style=\"font-size:12.0pt\">: These symptoms suggest involvement of the brachial plexus, a network of nerves that supplies the arm and hand. Pancoast tumors often invade or compress these nerves, leading to referred pain and sensory disturbances in the arm and hand.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Chest X-ray findings</span></strong><span style=\"font-size:12.0pt\">: The provided chest X-ray shows a mass at the apex of the lung, which is characteristic of a Pancoast tumor.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-114511.jpg\" style=\"height:306px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Upper lobe pneumonia</span></strong><span style=\"font-size:12.0pt\">: While upper lobe pneumonia can cause chest discomfort and possibly pain, it is not associated with Horner&#39;s syndrome or brachial plexus involvement. The X-ray findings would also typically show consolidation rather than a mass.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Superior vena cava obstruction</span></strong><span style=\"font-size:12.0pt\">: This condition can cause swelling and discoloration of the face, neck, and upper extremities due to impaired blood flow. However, it does not explain the specific nerve-related symptoms like Horner&#39;s syndrome or tingling in the digits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Aspergilloma</span></strong><span style=\"font-size:12.0pt\">: Aspergillomas are fungal balls that develop in pre-existing lung cavities, usually in patients with a history of tuberculosis or other lung diseases. They do not typically present with the neurological symptoms seen in this case, nor do they commonly cause Horner&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancoast tumors, or superior sulcus tumors, are associated with upper chest discomfort, Horner&#39;s syndrome, and neurological symptoms in the arm due to their apical location and propensity to invade local structures such as the brachial plexus and sympathetic nerves.</span></span></p>",
    "correct_choice_id": 81053,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74907,
    "choices": [
      {
        "id": 298525,
        "text": "<p><span style=\"font-size:16px;\">HLA B8</span></p>"
      },
      {
        "id": 298526,
        "text": "<p><span style=\"font-size:16px;\">HLA B27</span></p>"
      },
      {
        "id": 298527,
        "text": "<p><span style=\"font-size:16px;\">HLA B5</span></p>"
      },
      {
        "id": 298528,
        "text": "<p><span style=\"font-size:16px;\">HLA B51</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with uveitis and sacroiliitis. What is most likely associated with it? (INICET NOV 2024)</span></p>",
    "unique_key": "Q5045713",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233225,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) HLA B27</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The presentation of uveitis along with sacroiliitis is a classic manifestation of seronegative spondyloarthropathy, which is strongly associated with HLA-B27. These conditions are characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Inflammatory back pain</span></li><li><span style=\"font-size:16px;\">Early morning stiffness lasting more than one hour</span></li><li><span style=\"font-size:16px;\">Pain and stiffness that improve with exercise and worsen with rest</span></li><li><span style=\"font-size:16px;\">Anterior uveitis as the most common extra-articular manifestation</span></li><li><span style=\"font-size:16px;\">Sacroiliitis</span></li><li><span style=\"font-size:16px;\">Peripheral arthritis</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. HLA B8:</strong> Incorrect. Associated with good prognosis in sarcoidosis, not spondyloarthropathy</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. HLA B5:</strong> Incorrect. Associated with Beh\u00e7et's disease</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. HLA B51:</strong> Incorrect. Also associated with Beh\u00e7et's disease</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">HLA-B27 is strongly associated with seronegative spondyloarthropathies, particularly when patients present with the combination of uveitis and sacroiliitis.</span></p>",
    "correct_choice_id": 298526,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74879,
    "choices": [
      {
        "id": 298417,
        "text": "<p><span style=\"font-size:16px;\">Mask</span></p>"
      },
      {
        "id": 298418,
        "text": "<p><span style=\"font-size:16px;\">Vaccine</span></p>"
      },
      {
        "id": 298419,
        "text": "<p><span style=\"font-size:16px;\">Ivermectin</span></p>"
      },
      {
        "id": 298420,
        "text": "<p><span style=\"font-size:16px;\">Cough etiquette</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is considered ineffective in the prevention of COVID-19? (INICET NOV 2024)</span></p>",
    "unique_key": "Q3962113",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233198,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Ivermectin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ivermectin has been extensively studied during the COVID-19 pandemic but has not demonstrated any proven efficacy in preventing COVID-19 infection. Despite creating headlines during the pandemic period, clinical studies have not provided strong evidence that ivermectin reduces the risk of transmission or acquisition of COVID-19.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Mask:</strong> Wearing masks has been proven to be an effective preventive measure in reducing the transmission of COVID-19 by providing a physical barrier against respiratory droplets.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Vaccine:</strong> Vaccines serve as pre-exposure prophylaxis and have been demonstrated to be effective in preventing severe COVID-19 infection and reducing transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Cough etiquette:</strong> Proper cough etiquette is an important preventive measure that helps reduce the spread of respiratory droplets containing the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Ivermectin, despite being widely discussed during the pandemic, has not been proven effective in preventing COVID-19 infection, unlike established preventive measures such as masks, vaccines, and proper cough etiquette.</span></p>",
    "correct_choice_id": 298419,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74880,
    "choices": [
      {
        "id": 298421,
        "text": "<p><span style=\"font-size:16px;\">60\u201390 mL/min/1.73m\u00b2</span></p>"
      },
      {
        "id": 298422,
        "text": "<p><span style=\"font-size:16px;\">15\u201330 mL/min/1.73m\u00b2</span></p>"
      },
      {
        "id": 298423,
        "text": "<p><span style=\"font-size:16px;\">45\u201359 mL/min/1.73m\u00b2</span></p>"
      },
      {
        "id": 298424,
        "text": "<p><span style=\"font-size:16px;\">30\u201344 mL/min/1.73m\u00b2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">According to KDIGO staging of chronic kidney disease (CKD), what is the GFR range for stage 3b? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6481712",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233199,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 30\u201344 mL/min/1.73m\u00b2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Stage 3b CKD is defined by a GFR range of 30\u201344 mL/min/1.73m\u00b2. CKD stage 3 is divided into two subcategories:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Stage 3a: GFR 45\u201359 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 3b: GFR 30\u201344 mL/min/1.73m\u00b2</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">GFR ranges for CKD staging:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Stage 1: &gt;90 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 2: 60\u201389 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 3a: 45\u201359 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 3b: 30\u201344 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 4: 15\u201329 mL/min/1.73m\u00b2</span></li><li><span style=\"font-size:16px;\">Stage 5: &lt;15 mL/min/1.73m\u00b2</span></li></ul>",
    "correct_choice_id": 298424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20249,
    "choices": [
      {
        "id": 80957,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroid receptor antibody</span></p>"
      },
      {
        "id": 80958,
        "text": "<p><span style=\"font-size:12.0pt;\">Radioactive Iodine Uptake</span></p>"
      },
      {
        "id": 80959,
        "text": "<p><span style=\"font-size:12.0pt;\">Ultrasensitive thyrotropin</span></p>"
      },
      {
        "id": 80960,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-thyroid peroxidase antibody</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old medical student with a 2-month history of palpitations, sweating, and restlessness. He also complains of a sweaty palm. His appearance is as shown in the picture. What is the next step in evaluation? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-143515.jpg\" alt=\"\" width=\"300\" height=\"154\"></span></p>",
    "unique_key": "Q8785282",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233326,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ultrasensitive thyrotropin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms and the clinical image strongly suggest Graves' Orbitopathy (also known as Graves' Ophthalmopathy), characterized by proptosis, eyelid edema, and eye congestion. The most common cause of both unilateral and bilateral exophthalmos is Graves' disease, an autoimmune disorder leading to hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next step in evaluating a patient suspected of having hyperthyroidism is to perform a thyroid function test (TFT), with the most important initial test being the measurement of Thyroid Stimulating Hormone (TSH). The ultrasensitive thyrotropin test, which measures TSH levels, is crucial because it helps in determining the presence of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Graves' disease, TSH levels are typically very low or undetectable, while <strong>free T4</strong> and Total T3 levels are elevated (primary hyperthyroidism).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">IOC \u2013 MRI of the orbit</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TOC \u2013 mild \u2013 moderate disease \u2013 conservative management</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mod.-severe disease \u2013 first line TOC \u2013 CS (Dexamethasone); </span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">Teprotumumab (IGF1 receptor inhibitor Mab)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thyroid receptor antibody:</strong> This test is specific <strong>for confirming</strong> Graves' disease, but it is not the first step. It is used after initial thyroid function tests suggest hyperthyroidism to confirm the diagnosis. The antibodies known as TRAb (TSH receptor antibody/ Thyroid receptor Ab).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 forms of TRAb \u2013 TSI (Thyroid Stimulating Immunoglobulin) and</span></p><p style=\"margin-left:48px;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp; TBII (Thyroid binding Inhibitory Immunoglobulin)</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radioactive Iodine Uptake:</strong> This test helps to differentiate between various causes of hyperthyroidism, such as Graves' disease and toxic multinodular goiter. It is not the first step but follows initial thyroid function tests if hyperthyroidism is confirmed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Anti thyroid peroxidase antibody:</strong> This antibody is not specific for Graves' disease. It is more commonly associated with Hashimoto's thyroiditis and other autoimmune thyroid disorders, making it less relevant for initial evaluation in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The first and most crucial test in the evaluation of suspected hyperthyroidism, such as in a case suggestive of Graves' disease, is the measurement of ultrasensitive thyrotropin (TSH) levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confirmatory Diagnosis \u2013 by TRAbs (Thyroid receptor antibodies)</span></p>",
    "correct_choice_id": 80959,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "InvestigationBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74895,
    "choices": [
      {
        "id": 298477,
        "text": "<p><span style=\"font-size:16px;\">24 hr urinary total metanephrines</span></p>"
      },
      {
        "id": 298478,
        "text": "<p><span style=\"font-size:16px;\">MIBG scan</span></p>"
      },
      {
        "id": 298479,
        "text": "<p><span style=\"font-size:16px;\">Plasma catecholamines</span></p>"
      },
      {
        "id": 298480,
        "text": "<p><span style=\"font-size:16px;\">MRI of the whole abdomen</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is considered the initial recommended test for diagnosing pheochromocytoma? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6566243",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233213,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) 24 hr urinary total metanephrines</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The 24-hour urinary metanephrines test is considered the gold standard and first-line test for diagnosing pheochromocytoma in the general population. The test should include fractionated catecholamines for comprehensive evaluation. This test is preferred due to its high sensitivity and specificity in detecting these rare neuroendocrine tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. MIBG scan:</strong> This is a nuclear medicine imaging test that can be useful for localizing pheochromocytoma and ruling out multifocal or metastatic disease, but it's not the initial diagnostic test. It's typically performed after biochemical confirmation of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Plasma catecholamines:</strong> While plasma catecholamines can be measured as part of the routine testing, they are not as reliable as urinary metanephrines due to their fluctuating levels and potential for false positives.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. MRI of the whole abdomen:</strong> This is an imaging study used for tumor localization after biochemical confirmation of pheochromocytoma. It's not appropriate as an initial diagnostic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">A 24-hour urinary metanephrines test with fractionated catecholamines is the initial recommended test for diagnosing pheochromocytoma in the general population. Plasma metanephrines can be considered in high-risk populations (such as those with a family history or genetic syndromes).</span></p>",
    "correct_choice_id": 298477,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74896,
    "choices": [
      {
        "id": 298481,
        "text": "<p><span style=\"font-size:16px;\">Microangiopathic hemolytic anemia</span></p>"
      },
      {
        "id": 298482,
        "text": "<p><span style=\"font-size:16px;\">Thrombocytopenia</span></p>"
      },
      {
        "id": 298483,
        "text": "<p><span style=\"font-size:16px;\">Renal failure</span></p>"
      },
      {
        "id": 298484,
        "text": "<p><span style=\"font-size:16px;\">Thrombosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not a component of Thrombotic Thrombocytopenic Purpura (TTP)? (INICET NOV 2024)</span></p>",
    "unique_key": "Q7329846",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233214,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Thrombosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">TTP is characterized by a pentad of clinical findings:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Fever</span></li><li><span style=\"font-size:16px;\">Microangiopathic hemolytic anemia with schistocytes/helmet cells</span></li><li><span style=\"font-size:16px;\">Thrombocytopenia</span></li><li><span style=\"font-size:16px;\">Renal failure</span></li><li><span style=\"font-size:16px;\">Neurological involvement</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">TTP is caused by ADAMTS13 deficiency, which leads to excessive formation of platelet microthrombi in small vessels. While microvascular thrombosis occurs, macrovascular thrombosis is not a defining feature of TTP.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The classic pentad of TTP consists of fever, microangiopathic hemolytic anemia, thrombocytopenia, renal failure, and neurological involvement. Macrovascular thrombosis is not a defining feature of TTP, unlike in conditions such as antiphospholipid syndrome, where both macro- and microvascular thrombosis can occur.</span></p>",
    "correct_choice_id": 298484,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74914,
    "choices": [
      {
        "id": 298553,
        "text": "<p><span style=\"font-size:16px;\">Glu \u2192 Val (6)</span></p>"
      },
      {
        "id": 298554,
        "text": "<p><span style=\"font-size:16px;\">Lys \u2192 Arg (9)</span></p>"
      },
      {
        "id": 298555,
        "text": "<p><span style=\"font-size:16px;\">Glu \u2192 Lys (6)</span></p>"
      },
      {
        "id": 298556,
        "text": "<p><span style=\"font-size:16px;\">Ala \u2192 Gly (9)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which mutation is seen in sickle cell disease? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8220984",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233325,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Glu \u2192 Val (6)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell disease is caused by a specific <strong>point mutation at position 6 of the \u03b2-globin chain</strong>, where <strong>glutamic acid (Glu)</strong> is replaced by <strong>valine (Val)</strong>. This single amino acid substitution leads to the formation of <strong>abnormal hemoglobin S (HbS)</strong>, which polymerizes under deoxygenated conditions, causing red blood cells to become sickle-shaped.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell disease is caused by a point mutation at position 6 of the \u03b2-globin chain, where <strong>glutamic acid (Glu)</strong> is replaced by <strong>valine (Val)</strong>.</span></p>",
    "correct_choice_id": 298553,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74901,
    "choices": [
      {
        "id": 298501,
        "text": "<p><span style=\"font-size:16px;\">Medullary thyroid carcinoma</span></p>"
      },
      {
        "id": 298502,
        "text": "<p><span style=\"font-size:16px;\">Mucosal ganglioneuromatosis</span></p>"
      },
      {
        "id": 298503,
        "text": "<p><span style=\"font-size:16px;\">Parathyroid hyperplasia</span></p>"
      },
      {
        "id": 298504,
        "text": "<p><span style=\"font-size:16px;\">Marfanoid habitus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Features of MEN2B are all except: (INICET NOV 2024)</span></p>",
    "unique_key": "Q8100054",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233219,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Parathyroid hyperplasia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">MEN2B syndrome is characterized by a distinct set of clinical features known as the \"4 M's\":</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Marfanoid body habitus</span></li><li><span style=\"font-size:16px;\">Mucosal neuromas</span></li><li><span style=\"font-size:16px;\">Medullary thyroid carcinoma (MTC)</span></li><li><span style=\"font-size:16px;\">Megacolon (Hirschsprung disease)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\">Additionally, pheochromocytoma is also a feature of MEN2B. The syndrome is caused by mutations in the RET proto-oncogene located on chromosome 10.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Parathyroid hyperplasia is NOT a component of MEN2B syndrome, while the characteristic features include medullary thyroid carcinoma, mucosal neuromas, marfanoid habitus, and megacolon (the 4 M's).</span></p>",
    "correct_choice_id": 298503,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74899,
    "choices": [
      {
        "id": 298493,
        "text": "<p><span style=\"font-size:16px;\">Decrease in Bowman's capsule hydrostatic pressure&nbsp;</span></p>"
      },
      {
        "id": 298494,
        "text": "<p><span style=\"font-size:16px;\">Increase in glomerular hydrostatic pressure</span></p>"
      },
      {
        "id": 298495,
        "text": "<p><span style=\"font-size:16px;\">Decrease in glomerular filtration coefficient&nbsp;</span></p>"
      },
      {
        "id": 298496,
        "text": "<p><span style=\"font-size:16px;\">Decrease in glomerular oncotic pressure&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">What causes decrease in GFR? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6483080",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233217,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Decrease in glomerular filtration coefficient</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The glomerular filtration coefficient (Kf) is directly proportional to GFR according to the formula. Therefore, a decrease in Kf will lead to a decrease in GFR. The filtration coefficient represents the product of the hydraulic permeability and surface area available for filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Decrease in Bowman's capsule hydrostatic pressure:</strong> Incorrect. A decrease in Bowman's capsule hydrostatic pressure will increase GFR by increasing the net filtration pressure gradient.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Increase in glomerular hydrostatic pressure:</strong> Incorrect. An increase in glomerular hydrostatic pressure increases GFR by promoting filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Decrease in glomerular oncotic pressure:</strong> Incorrect. A decrease in glomerular oncotic pressure increases GFR by reducing the opposition to filtration.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glomerular filtration coefficient (Kf) and GFR are directly proportional, meaning a decrease in Kf causes a decrease in GFR.</span></p>",
    "correct_choice_id": 298495,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20261,
    "choices": [
      {
        "id": 81005,
        "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 81006,
        "text": "<p><span style=\"font-size:12.0pt;\">Squatting</span></p>"
      },
      {
        "id": 81007,
        "text": "<p><span style=\"font-size:12.0pt;\">Valsalva</span></p>"
      },
      {
        "id": 81008,
        "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following would most likely lead to a decrease in the intensity of the murmur in a patient with hypertrophic cardiomyopathy? (NEET PG 2023)</span></p>",
    "unique_key": "Q9642752",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233332,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Squatting</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hypertrophic cardiomyopathy (HCM), the intensity of the murmur is influenced by the left ventricular outflow tract (LVOT) obstruction. Various maneuvers and medications can affect this obstruction by altering preload (the volume of blood in the ventricles before contraction) or afterload (the resistance the heart must pump against).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Squatting</strong> increases preload by squeezing the peripheral veins and increasing venous return to the heart. This increase in preload reduces LVOT obstruction, thereby decreasing the murmur's intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Digoxin:</strong> Digoxin increases contractility. In HCM, increased contractility can worsen LVOT obstruction, thereby increasing the intensity of the murmur and worsening the murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Valsalva</strong>: The Valsalva maneuver reduces preload by decreasing venous return to the heart. This reduction in preload can increase LVOT obstruction, leading to a louder murmur.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Furosemide</strong>: By reducing preload, furosemide increases LVOT obstruction and murmur intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Increasing preload (e.g., through squatting) reduces LVOT obstruction in hypertrophic cardiomyopathy, leading to a decrease in the murmur's intensity.</span></p>",
    "correct_choice_id": 81006,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74903,
    "choices": [
      {
        "id": 298509,
        "text": "<p><span style=\"font-size:16px;\">1-C, 2-B, 3-D, 4-A</span></p>"
      },
      {
        "id": 298510,
        "text": "<p><span style=\"font-size:16px;\">1-D, 2-A, 3-C, 4-B</span></p>"
      },
      {
        "id": 298511,
        "text": "<p><span style=\"font-size:16px;\">1-A, 2-B, 3-C, 4-D</span></p>"
      },
      {
        "id": 298512,
        "text": "<p><span style=\"font-size:16px;\">1-B, 2-A, 3-D, 4-C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Match the following hormones to receptors: (INICET NOV 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_yEQI1e3.png\" width=\"872\" height=\"262\"></span></p>",
    "unique_key": "Q9861720",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233221,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) 1-B, 2-A, 3-D, 4-C</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\"><strong>(1-B)</strong> Acetylcholine works through ligand-gated channels (like other neurotransmitters such as serotonin and GABA)</span></li><li><span style=\"font-size:16px;\"><strong>(2-A)</strong> Insulin functions via the receptor tyrosine kinase (RTK) pathway, with insulin receptor substrate (IRS) as its substrate</span></li><li><span style=\"font-size:16px;\"><strong>(3-D)</strong> Growth hormone operates through the JAK-STAT pathway (non-receptor tyrosine kinase pathway)</span></li><li><span style=\"font-size:16px;\"><strong>(4-C)</strong> Thyroxine, being lipid-soluble, acts through nuclear receptors</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The distinct receptor mechanisms for different hormone classes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Acetylcholine \u2192 Ligand-gated channels</span></li><li><span style=\"font-size:16px;\">Insulin \u2192 Tyrosine kinase pathway</span></li><li><span style=\"font-size:16px;\">Growth hormone \u2192 JAK-STAT pathway</span></li><li><span style=\"font-size:16px;\">Thyroxine \u2192 Nuclear receptors</span></li></ul>",
    "correct_choice_id": 298512,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74909,
    "choices": [
      {
        "id": 298533,
        "text": "<p><span style=\"font-size:16px;\">Vitamin B12 deficiency</span></p>"
      },
      {
        "id": 298534,
        "text": "<p><span style=\"font-size:16px;\">Vitamin B6 deficiency</span></p>"
      },
      {
        "id": 298535,
        "text": "<p><span style=\"font-size:16px;\">Thiamine deficiency</span></p>"
      },
      {
        "id": 298536,
        "text": "<p><span style=\"font-size:16px;\">Folic acid deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient complained of bilateral lower limb numbness. He has a history of low BP and gastrectomy done for gastric cancer a year back. On examination, Romberg test is positive and there is loss of proprioception in both lower limbs. Which of the following deficiency can cause this condition? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2222365",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233320,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Vitamin B12 deficiency</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This patient's presentation strongly suggests Vitamin B12 deficiency for several reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>History of gastrectomy</strong> \u2013 Loss of stomach leads to loss of intrinsic factor, essential for B12 absorption</span></li><li><span style=\"font-size:16px;\"><strong>Neurological symptoms</strong> \u2013 Bilateral lower limb numbness</span></li><li><span style=\"font-size:16px;\"><strong>Positive Romberg test and loss of proprioception</strong> indicate posterior column involvement, which is characteristic of subacute combined degeneration of the spinal cord seen in B12 deficiency</span></li><li><span style=\"font-size:16px;\">The combination of gastrectomy and neurological symptoms is classic for B12 deficiency</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Vitamin B6 deficiency:</strong> While it can cause peripheral neuropathy, it doesn't typically cause posterior column signs</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Thiamine deficiency:</strong> Primarily causes Wernicke's encephalopathy and cardiovascular symptoms; doesn't typically present with proprioception loss; more commonly seen in alcoholics</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Folic acid deficiency:</strong> Primarily causes hematological manifestations; does not cause neurological symptoms like B12 deficiency</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Gastrectomy leads to B12 deficiency due to loss of intrinsic factor, and B12 deficiency can cause subacute combined degeneration of the spinal cord, presenting with posterior column signs (proprioception loss and positive Romberg test).</span></p>",
    "correct_choice_id": 298533,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52809,
    "choices": [
      {
        "id": 210725,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute hepatitis B</span></span></span></p>"
      },
      {
        "id": 210726,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute hepatitis C</span></span></span></p>"
      },
      {
        "id": 210727,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic hepatitis B</span></span></span></p>"
      },
      {
        "id": 210728,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic hepatitis C</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presents to you with fever, jaundice, and malaise. What is the most likely diagnosis based on the serology reports given below? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-HBc (IgM): Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">HBsAg: Positive</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-HBs: Negative</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-HCV antibodies: Negative</span></span></li>\r\n</ul>",
    "unique_key": "Q7744876",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233366,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Acute hepatitis B</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The serology results provide crucial information for diagnosing the type of hepatitis the patient has:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">HBsAg (Hepatitis B surface antigen): Positive</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This indicates an active hepatitis B infection, as HBsAg is a marker of infection.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HBc (IgM) (Hepatitis B core antibody, IgM): Positive</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of IgM anti-HBc indicates a recent infection or acute hepatitis B. IgM is produced early in the infection and suggests that the infection is recent.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HBs (Hepatitis B surface antibody): Negative</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The absence of anti-HBs indicates that the patient has not resolved the infection or been vaccinated. In the context of acute infection, this is expected as the patient has not yet developed immunity.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Anti-HCV antibodies: Negative</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This indicates that the patient does not have hepatitis C.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Based on these results, the diagnosis is <strong>acute hepatitis B</strong>. The presence of HBsAg and IgM anti-HBc are key indicators of an acute infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute hepatitis C</span></strong><span style=\"font-size:12.0pt\">: This is ruled out by the negative anti-HCV antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chronic hepatitis B</span></strong><span style=\"font-size:12.0pt\">: Chronic hepatitis B is diagnosed when HBsAg persists for more than six months and is typically associated with IgG anti-HBc, not IgM.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic hepatitis C</span></strong><span style=\"font-size:12.0pt\">: This is ruled out by the negative anti-HCV antibodies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The presence of HBsAg and IgM anti-HBc in a patient with fever, jaundice, and malaise strongly indicates acute hepatitis B.</span></span></p>",
    "correct_choice_id": 210725,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20251,
    "choices": [
      {
        "id": 80965,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic Regurgitation</span></p>"
      },
      {
        "id": 80966,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral Regurgitation</span></p>"
      },
      {
        "id": 80967,
        "text": "<p><span style=\"font-size:12.0pt;\">Mitral Stenosis</span></p>"
      },
      {
        "id": 80968,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic Stenosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Among the given options, murmur given in the image is associated with? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/29/whatsapp-image-2023-06-12-at-1901276.jpg\" alt=\"\" width=\"400\" height=\"70\"></span></p>",
    "unique_key": "Q7877972",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233327,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Mitral Regurgitation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image provided indicates a murmur occurring between S1 and S2, which is described as <strong>a pan-systolic murmur</strong>. This type of murmur spans the entirety of systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mitral Regurgitation</strong> produces a pan-systolic murmur due to the backward flow of blood from the left ventricle into the left atrium throughout systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aortic Regurgitation:</strong> Characterized by an <strong>early diastolic murmur</strong> due to backflow of blood from the aorta into the left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mitral Stenosis:</strong> Characterized by a <strong>mid-diastolic murmur</strong> due to obstructed blood flow from the left atrium to the left ventricle during diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aortic Stenosis:</strong> Characterized by an <strong>ejection systolic murmur</strong> due to turbulent blood flow across a narrowed aortic valve during systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mitral regurgitation is associated with a pan-systolic murmur, which is present throughout the systole and heard between the S1 and S2 heart sounds.</span></p>",
    "correct_choice_id": 80966,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11352,
    "choices": [
      {
        "id": 45374,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous salbutamol</span></span></span></p>"
      },
      {
        "id": 45375,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></span></span></p>"
      },
      {
        "id": 45376,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nebulization with salbutamol</span></span></span></p>"
      },
      {
        "id": 45377,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen and antibiotics</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is non-compliant with medication presents to you with sudden onset breathlessness. A chest X-ray was done, which is shown below. How will you manage this patient? (Neet pg 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/29/screenshot-2024-07-29-191623.jpg\" style=\"height:305px; width:400px\" /></p>",
    "unique_key": "Q1210870",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233375,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Intravenous nitroglycerin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms and signs indicative of pulmonary edema, which is evident from the chest X-ray showing interstitial edema and classic bat-wing appearance, suggestive of cardiogenic pulmonary edema. The history of hypertension and non-compliance with medication supports the diagnosis, as poorly controlled hypertension can lead to increased afterload, left ventricular failure, and subsequent pulmonary edema.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Intravenous nitroglycerin</span></strong><span style=\"font-size:12.0pt\">: Nitroglycerin is the treatment of choice in this scenario as it helps to reduce both preload and afterload by dilating veins and arteries. This leads to a reduction in pulmonary congestion and improvement in symptoms of breathlessness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Intravenous salbutamol</span></strong><span style=\"font-size:12.0pt\">: Salbutamol is a bronchodilator used primarily in the treatment of asthma or COPD exacerbations, and primarily not used intravenously. It is not indicated for managing pulmonary edema and does not address the underlying cause of fluid accumulation in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nebulization with salbutamol</span></strong><span style=\"font-size:12.0pt\">: Similar to intravenous salbutamol, nebulized salbutamol is used for bronchodilation in conditions like asthma or COPD. It is not effective in treating pulmonary edema and does not relieve the symptoms caused by fluid overload in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Oxygen and antibiotics</span></strong><span style=\"font-size:12.0pt\">: While oxygen might be necessary to support the patient&rsquo;s respiratory status, antibiotics are not indicated unless there is a concurrent infection, which is not suggested by the patient&rsquo;s presentation. The primary issue here is fluid overload due to heart failure, not an infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of cardiogenic pulmonary edema, intravenous nitroglycerin is essential to reduce preload and afterload, thereby alleviating pulmonary congestion and improving the patient&#39;s symptoms.</span></span></p>",
    "correct_choice_id": 45375,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50966,
    "choices": [
      {
        "id": 203405,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addison&#39;s disease&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203406,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gigantism&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203407,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly</span></span></span></span></p>"
      },
      {
        "id": 203408,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cushing&#39;s syndrome&nbsp;</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These findings are suggestive of which of the following conditions</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-113157.png\" style=\"height:174px; width:300px\" /></span></span></p>",
    "unique_key": "Q2208116",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233190,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">) <strong>Acromegaly</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The images provided show a patient with coarse facial features, prognathism (protruding jaw), frontal bossing (prominent forehead), and prominent jaw bones. These are characteristic features of acromegaly, a condition caused by excessive growth hormone (GH) production, usually due to a pituitary adenoma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Addison&#39;s disease:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by hyperpigmentation, hypotension, and weight loss, not by coarse facial features.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gigantism:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also caused by excess GH, but it occurs before the closure of the growth plates in children and adolescents, leading to increased height and growth of long bones. The facial features are not as prominent as in acromegaly.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cushing&#39;s syndrome:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Characterized by features such as central obesity, moon face, buffalo hump, and purple striae, not by coarse facial features and prognathism.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly is diagnosed based on characteristic facial features such as coarse facial features, prognathism, and frontal bossing, resulting from excessive growth hormone production.</span></span></p>",
    "correct_choice_id": 203407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74883,
    "choices": [
      {
        "id": 298433,
        "text": "<p><span style=\"font-size:16px;\">Diarrhea</span></p>"
      },
      {
        "id": 298434,
        "text": "<p><span style=\"font-size:16px;\">Diabetic ketoacidosis (DKA)</span></p>"
      },
      {
        "id": 298435,
        "text": "<p><span style=\"font-size:16px;\">Acute renal failure</span></p>"
      },
      {
        "id": 298436,
        "text": "<p><span style=\"font-size:16px;\">Inborn errors of metabolism</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">High Anion Gap Metabolic Acidosis (HAGMA) is not caused by: (INICET NOV 2024)</span></p>",
    "unique_key": "Q1263186",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233202,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Diarrhea</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diarrhea causes Normal Anion Gap Metabolic Acidosis (NAGMA), not High Anion Gap Metabolic Acidosis (HAGMA). There are only three main causes of NAGMA, remembered by the mnemonic \"DRS\":</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">D: Diarrhea</span></li><li><span style=\"font-size:16px;\">R: RTA (Renal Tubular Acidosis \u2013 types 1, 2, and 4)</span></li><li><span style=\"font-size:16px;\">S: Saline administration (causing hyperchloremic metabolic acidosis)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Diabetic ketoacidosis (DKA):</strong> Incorrect. DKA is a classic cause of HAGMA. It leads to accumulation of ketone bodies, causing high anion gap.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Acute renal failure:</strong> Incorrect. Renal failure causes HAGMA due to accumulation of organic acids and decreased acid excretion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Inborn errors of metabolism:</strong> Incorrect. Most inborn errors of metabolism cause HAGMA through accumulation of organic acids.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The causes of HAGMA can be remembered using the mnemonic <strong>\"GOLDMARK\"</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">G: Glycol (ethylene glycol)</span></li><li><span style=\"font-size:16px;\">O: Oxoproline (paracetamol metabolite)</span></li><li><span style=\"font-size:16px;\">L: L-lactate</span></li><li><span style=\"font-size:16px;\">D: D-lactate (short bowel syndrome)</span></li><li><span style=\"font-size:16px;\">M: Methanol</span></li><li><span style=\"font-size:16px;\">A: Aspirin</span></li><li><span style=\"font-size:16px;\">R: Renal failure</span></li><li><span style=\"font-size:16px;\">K: Ketoacidosis (diabetic, alcoholic, starvation)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Diarrhea causes Normal Anion Gap Metabolic Acidosis (NAGMA), not High Anion Gap Metabolic Acidosis (HAGMA).</span></p>",
    "correct_choice_id": 298433,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74877,
    "choices": [
      {
        "id": 298409,
        "text": "<p><span style=\"font-size:16px;\">HCV</span></p>"
      },
      {
        "id": 298410,
        "text": "<p><span style=\"font-size:16px;\">HAV (Hepatitis A Virus)</span></p>"
      },
      {
        "id": 298411,
        "text": "<p><span style=\"font-size:16px;\">HDV</span></p>"
      },
      {
        "id": 298412,
        "text": "<p><span style=\"font-size:16px;\">HBV</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following viruses spreads predominantly through water? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1183709",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233196,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) HAV (Hepatitis A Virus)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepatitis A virus (HAV) primarily spreads through the fecal-oral route and contaminated water. It is one of the main viral pathogens that uses water as its predominant transmission route. The virus is highly stable in water and sewage, making waterborne transmission a significant public health concern, especially in areas with poor sanitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. HCV (Hepatitis C Virus):</strong> Incorrect because HCV spreads predominantly through the parenteral route, particularly through needlestick injuries, blood transfusions, and surgical procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. HDV (Hepatitis D Virus):</strong> Incorrect because HDV is a dependent virus that requires the presence of HBV for its replication and transmission. It cannot spread independently through water.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. HBV (Hepatitis B Virus):</strong> Incorrect because HBV primarily spreads through vertical transmission (mother to child) in developing countries like India. While sexual transmission is possible, it's relatively rare. It does not spread through water.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hepatitis A virus spreads predominantly through the fecal-oral route and contaminated water, unlike other hepatitis viruses, which have different primary modes of transmission.</span></p>",
    "correct_choice_id": 298410,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74910,
    "choices": [
      {
        "id": 298537,
        "text": "<p><span style=\"font-size:16px;\">Protein C deficiency</span></p>"
      },
      {
        "id": 298538,
        "text": "<p><span style=\"font-size:16px;\">PNH (Paroxysmal Nocturnal Hemoglobinuria)</span></p>"
      },
      {
        "id": 298539,
        "text": "<p><span style=\"font-size:16px;\">Factor V Leiden mutation</span></p>"
      },
      {
        "id": 298540,
        "text": "<p><span style=\"font-size:16px;\">Antithrombin III deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">All are hereditary causes of thrombosis except: (INICET NOV 2024)</span></p>",
    "unique_key": "Q9705947",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233321,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) PNH (Paroxysmal Nocturnal Hemoglobinuria)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PNH is an <strong>acquired</strong> stem cell disorder, not a hereditary condition. It occurs due to a <strong>somatic mutation in the PIG-A gene</strong> that produces GPI (glycosyl phosphatidylinositol) anchors. This defect affects proteins <strong>CD55 and CD59</strong> (also known as DAF and MIRL respectively), which are important complement regulatory proteins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option&nbsp;A. Protein C deficiency:</strong> Hereditary cause of thrombosis; Protein C is a natural anticoagulant</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C.</strong> <strong>Factor V Leiden mutation:&nbsp;</strong>Most common inherited cause of thrombophilia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D.</strong> <strong>Antithrombin III deficiency:&nbsp;</strong>Inherited condition increasing thrombotic risk</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">PNH is an <strong>acquired</strong> (not hereditary) stem cell disorder caused by somatic mutations in the PIG-A gene. Protein C deficiency, Factor V Leiden mutation, and Antithrombin III deficiency are <strong>hereditary</strong> causes of thrombophilia.</span></p>",
    "correct_choice_id": 298538,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74900,
    "choices": [
      {
        "id": 298497,
        "text": "<p><span style=\"font-size:16px;\">A, B</span></p>"
      },
      {
        "id": 298498,
        "text": "<p><span style=\"font-size:16px;\">A only</span></p>"
      },
      {
        "id": 298499,
        "text": "<p><span style=\"font-size:16px;\">A, B and C</span></p>"
      },
      {
        "id": 298500,
        "text": "<p><span style=\"font-size:16px;\">A, B, D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following findings are typically associated with glomerular hematuria? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:16px;\">Brown urine</span></li><li><span style=\"font-size:16px;\">Dysuria absent</span></li><li><span style=\"font-size:16px;\">Crystals in urine</span></li><li><span style=\"font-size:16px;\">Edema is rare</span></li></ol>",
    "unique_key": "Q8668544",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233218,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) A, B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glomerular hematuria has specific characteristics that help differentiate it from non-glomerular causes:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>A.&nbsp;Brown urine:</strong> Brown/cola-colored urine is typical of glomerular hematuria due to the presence of RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>B.&nbsp;Dysuria absent:</strong> Absence of dysuria is characteristic, as there is no urinary tract inflammation or infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These findings together strongly suggest glomerular origin of hematuria.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>C. Crystals in urine:&nbsp;</strong>Incorrect. Crystalluria is not a feature of glomerular hematuria. Instead, findings like dysmorphic RBCs, acanthocytes, or RBC casts are characteristic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>D. Edema is rare:</strong> Incorrect. Edema is common in glomerular diseases, whether nephritic or nephrotic, due to:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Loss of albumin leading to decreased oncotic pressure</span></li><li><span style=\"font-size:16px;\">Activation of the renin-angiotensin system</span></li><li><span style=\"font-size:16px;\">Underlying inflammatory processes</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Glomerular hematuria includes brown/cola-colored urine and absence of dysuria, while presence of edema and absence of urinary crystals are other important characteristics.</span></p>",
    "correct_choice_id": 298497,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74898,
    "choices": [
      {
        "id": 298489,
        "text": "<p><span style=\"font-size:16px;\">E. coli O157:H7</span></p>"
      },
      {
        "id": 298490,
        "text": "<p><span style=\"font-size:16px;\">Shigella flexneri</span></p>"
      },
      {
        "id": 298491,
        "text": "<p><span style=\"font-size:16px;\">Salmonella enteritis</span></p>"
      },
      {
        "id": 298492,
        "text": "<p><span style=\"font-size:16px;\">Aeromonas</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A 2-year-old child presented with fever, thrombocytopenia, and hematuria. The mother tells you that the baby also suffered from bloody diarrhea a few days back. Which is likely microorganism to be isolated from the stool sample? (INICET NOV 2024)</span></p>",
    "unique_key": "Q3251520",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233216,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) E. coli O157:H7</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The clinical presentation strongly suggests Hemolytic Uremic Syndrome (HUS) based on the triad of:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Hematuria</span></li><li><span style=\"font-size:16px;\">Thrombocytopenia</span></li><li><span style=\"font-size:16px;\">History of bloody diarrhea</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">E. coli O157:H7, also known as Shiga toxin-producing E. coli (STEC) or Enterohemorrhagic E. coli (EHEC), is the most common causative organism of HUS, particularly in children.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Shigella flexneri</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Incorrect because while it can cause bloody diarrhea, it is more commonly associated with reactive arthritis rather than HUS.</span></li><li><span style=\"font-size:16px;\">Does not typically cause the combination of hematuria and thrombocytopenia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Salmonella enteritis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Incorrect as it is primarily associated with osteomyelitis in patients with sickle cell disease.</span></li><li><span style=\"font-size:16px;\">Not typically associated with HUS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Aeromonas</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Incorrect as it typically causes simple diarrhea without the complications of HUS.</span></li><li><span style=\"font-size:16px;\">Does not produce Shiga toxin, which is responsible for HUS.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">E. coli O157:H7 is the most common cause of Hemolytic Uremic Syndrome in children, typically presenting with bloody diarrhea followed by the triad of hemolytic anemia, thrombocytopenia, and acute kidney injury.</span></p>",
    "correct_choice_id": 298489,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74890,
    "choices": [
      {
        "id": 298457,
        "text": "<p><span style=\"font-size:16px;\">Creatinine raised by 5%</span></p>"
      },
      {
        "id": 298458,
        "text": "<p><span style=\"font-size:16px;\">Any rise in creatinine</span></p>"
      },
      {
        "id": 298459,
        "text": "<p><span style=\"font-size:16px;\">Creatinine raised by 10%</span></p>"
      },
      {
        "id": 298460,
        "text": "<p><span style=\"font-size:16px;\">Not associated with rise in Creatinine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Acute graft rejection in a kidney transplant patient is indicated by: (INICET NOV 2024)</span></p>",
    "unique_key": "Q3060973",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233208,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Any rise in creatinine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In modern transplant medicine, acute graft rejection often presents subtly due to powerful immunosuppression regimens. The most common presentation of acute rejection in current clinical practice is an asymptomatic rise in serum creatinine. According to the definition, there should be at least a 25% increase in serum creatinine to diagnose acute rejection. However, in cases where antibody-mediated rejection (ABMR) is suspected, any rise in serum creatinine can lead to a diagnosis or at least a suspicion of acute rejection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Creatinine raised by 5%:</strong> Incorrect because acute rejection is characterized by a rise in creatinine levels. Normal creatinine would not indicate rejection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Creatinine raised by 10%:</strong> While this would also indicate rejection, the question asks for the earliest indicator, and any rise in creatinine (including 5%) should raise suspicion.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Not associated with rise in Creatinine:</strong> Incorrect because there is a clear association between creatinine rises and acute rejection. This is one of the most reliable indicators of rejection.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Acute graft rejection in kidney transplant patients typically presents with asymptomatic elevation in serum creatinine. Traditional symptoms like fever and graft tenderness are less common due to current immunosuppression protocols. Any rise in creatinine should prompt consideration of acute rejection.</span></p>",
    "correct_choice_id": 298458,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "DiagnosisBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74886,
    "choices": [
      {
        "id": 298441,
        "text": "<p><span style=\"font-size:16px;\">Female sex workers</span></p>"
      },
      {
        "id": 298442,
        "text": "<p><span style=\"font-size:16px;\">Long distance truck drivers</span></p>"
      },
      {
        "id": 298443,
        "text": "<p><span style=\"font-size:16px;\">Male having sex with male</span></p>"
      },
      {
        "id": 298444,
        "text": "<p><span style=\"font-size:16px;\">IV drug abusers</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following groups is not considered a core risk factor group for HIV transmission? (INICET NOV 2024)</span></p>",
    "unique_key": "Q1660988",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233204,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Long-distance truck drivers</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The core risk groups for HIV transmission are populations that primarily transmit the disease to bridge populations, who then transmit it to the general population. In endemic countries like India, addressing these core groups is crucial for reducing HIV transmission rates. The core high-risk groups include female sex workers, men who have sex with men (MSM), transgender populations, and injectable drug users.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Long-distance truck drivers are considered a <strong>bridge population</strong> rather than a core risk group. While they are important in the transmission chain, they act as intermediaries between core risk groups and the general population.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_93334Gb.png\" width=\"655\" height=\"686\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dcL1dbs.png\" width=\"1157\" height=\"161\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Female sex workers:</strong> Incorrect. This is a core risk group according to NACO 2024 data and is one of the primary populations targeted for HIV prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Male having sex with male (MSM):</strong> Incorrect. MSM is a core high-risk group that requires focused intervention for HIV prevention.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. IV drug abusers:</strong> Incorrect. Injectable drug users are considered a core high-risk group for HIV transmission.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The distinction between core risk groups and bridge populations in HIV transmission:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Core risk groups include:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Female sex workers</span></li><li><span style=\"font-size:16px;\">Men who have sex with men (MSM)</span></li><li><span style=\"font-size:16px;\">Transgender populations</span></li><li><span style=\"font-size:16px;\">Injectable drug users</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Bridge populations</strong>, like truck drivers and migrants, serve as intermediaries in disease transmission.</span></p>",
    "correct_choice_id": 298442,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50962,
    "choices": [
      {
        "id": 203389,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor X deficiency&nbsp;</span></p>"
      },
      {
        "id": 203390,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor VIII deficiency&nbsp;</span></p>"
      },
      {
        "id": 203391,
        "text": "<p><span style=\"font-size:12.0pt;\">Factor IX deficiency&nbsp;</span></p>"
      },
      {
        "id": 203392,
        "text": "<p><span style=\"font-size:12.0pt;\">Von Willebrand Disease&nbsp;</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 26-year-old female presents to the ER with menorrhagia. She mentions that her father and sister also suffer from bleeding disorders. Which of the following is likely? </span><span style=\"font-size:10pt;\">(INICET NOV 2023)</span></p>",
    "unique_key": "Q4715248",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233188,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Von Willebrand Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Von Willebrand Disease (vWD) is the most likely diagnosis given the family history of bleeding disorders and the patient's presentation with menorrhagia. vWD is an autosomal dominant condition affecting both males and females, characterized by defective platelet function due to a deficiency or dysfunction of von Willebrand factor. This leads to symptoms such as prolonged bleeding, menorrhagia, and prolonged bleeding after dental extractions or surgeries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Factor X deficiency: An</strong> extremely rare autosomal recessive condition that typically presents with joint bleeding (hemarthrosis) and intramuscular hematomas, which are more indicative of coagulation disorders rather than bleeding tendencies seen in platelet disorders.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Factor VIII deficiency:</strong> Known as Hemophilia A, this is an X-linked recessive disorder affecting mostly males. Females are typically carriers and rarely show symptoms. Hemophilia A presents with severe bleeding episodes and hemarthrosis, not usually menorrhagia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Factor IX deficiency</strong>: Known as Hemophilia B, this is also an X-linked recessive disorder affecting mostly males, with similar presentations to Hemophilia A, including severe bleeding episodes and hemarthrosis, not typically menorrhagia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Von Willebrand Disease is an autosomal dominant disorder presenting with bleeding symptoms like menorrhagia and is more common in females compared to Hemophilia A or B, which are X-linked recessive and primarily affect males.</span></p>",
    "correct_choice_id": 203392,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20271,
    "choices": [
      {
        "id": 81045,
        "text": "<p><span style=\"font-size:12.0pt;\">DDAVP for 2 weeks and then discontinue</span></p>"
      },
      {
        "id": 81046,
        "text": "<p><span style=\"font-size:12.0pt;\">DDAVP supplementation for lifelong</span></p>"
      },
      {
        "id": 81047,
        "text": "<p><span style=\"font-size:12.0pt;\">Upsetting of receptors so no treatment is required</span></p>"
      },
      {
        "id": 81048,
        "text": "<p><span style=\"font-size:12.0pt;\">Thiazides for 2 weeks</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient came to the medical OPD with complaints of polyuria. He has a history of undergoing total hypophysectomy. His Na<sup>+</sup> levels are found to be 155 mEq/L, urine osmolality was 200 mOsm/L. What is the definitive management? (NEET PG 2023)</span></p>",
    "unique_key": "Q6225083",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233339,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. DDAVP supplementation for lifelong</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of polyuria and low urine osmolality (200 mOsm/L) with hypernatremia (Na+ 155 mEq/L) is indicative of diabetes insipidus (DI). Given the history of total hypophysectomy, this is most likely central diabetes insipidus (CDI), where the pituitary gland no longer produces antidiuretic hormone (ADH, also known as vasopressin).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In CDI, the definitive treatment is <strong>desmopressin (DDAVP</strong>), a synthetic analog of ADH. Desmopressin helps to reduce urine output and correct hypernatremia by promoting water reabsorption in the kidneys. Since the condition is permanent due to the hypophysectomy, lifelong supplementation with desmopressin is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. DDAVP for 2 weeks and then discontinue:</strong> Discontinuing DDAVP after 2 weeks is not appropriate as the patient will continue to suffer from polyuria and hypernatremia due to the lack of ADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Upsetting of receptors so no treatment is required</strong>: This option is incorrect as the patient's symptoms and lab findings clearly indicate the need for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Thiazides for 2 weeks:</strong> Thiazides are used in nephrogenic diabetes insipidus (NDI) to reduce urine output by increasing ADH sensitivity. However, in central diabetes insipidus, thiazides are not effective because the issue is the absence of ADH, not a problem with the kidneys' response to it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with central diabetes insipidus following total hypophysectomy, lifelong desmopressin (DDAVP) supplementation is required to manage symptoms and prevent complications from persistent polyuria and hypernatremia.</span></p>",
    "correct_choice_id": 81046,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20254,
    "choices": [
      {
        "id": 80977,
        "text": "<p><span style=\"font-size:12.0pt;\">Parkinson\u2019s Disease</span></p>"
      },
      {
        "id": 80978,
        "text": "<p><span style=\"font-size:12.0pt;\">Prion\u2019s Disease</span></p>"
      },
      {
        "id": 80979,
        "text": "<p><span style=\"font-size:12.0pt;\">Huntington\u2019s Disease</span></p>"
      },
      {
        "id": 80980,
        "text": "<p><span style=\"font-size:12.0pt;\">Alzheimer\u2019s Disease</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An 80-year-old woman presents with a progressive decline in daily activity. She gives a history of staring into space with frequent visual hallucinations. Pathology reveals Lewy bodies in neurons. What is the most likely diagnosis? (NEET PG 2023)</span></p>",
    "unique_key": "Q8942357",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233329,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Parkinson\u2019s Disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence <strong>of Lewy bodies,</strong> which are <strong>aggregates of alpha-synuclein protein</strong>, in neurons suggests either Parkinson's disease or Lewy body dementia. Given the patient's symptoms of progressive decline in daily activity, visual hallucinations, and pathology findings, Parkinson's disease is the most likely diagnosis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lewy Bodies:</strong> These are characteristic of Parkinson\u2019s disease and Lewy body dementia. They are intraneuronal inclusions primarily composed of alpha-synuclein.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Visual Hallucinations:</strong> These are more common in Parkinson's disease and Lewy body dementia compared to other neurodegenerative disorders.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Parkinson\u2019s Disease:</strong> The diagnosis is supported by the clinical history of visual hallucinations and progressive decline, alongside the pathological finding of Lewy bodies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Prion\u2019s Disease:</strong> Typically presents with rapidly progressing dementia and myoclonus. EEG shows characteristic periodic sharp wave complexes, and CSF may show elevated 14.3.3 protein. This does not match the patient's clinical picture.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Huntington\u2019s Disease</strong>: An inherited condition characterized by the classic triad of dementia, chorea, and psychiatric manifestations. This condition usually presents earlier in life and has a strong family history component.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alzheimer\u2019s Disease:</strong> Primarily presents with memory loss and later with visual-spatial problems and the \"four A\u2019s\" (amnesia, agnosia, apraxia, aphasia). Pathologically, it is characterized by beta-amyloid plaques and tau protein tangles, not Lewy bodies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Lewy bodies in neurons and clinical features such as visual hallucinations and progressive decline in activity are indicative of Parkinson\u2019s disease.</span></p>",
    "correct_choice_id": 80977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20262,
    "choices": [
      {
        "id": 81009,
        "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
      },
      {
        "id": 81010,
        "text": "<p><span style=\"font-size:12.0pt;\">Tenofovir</span></p>"
      },
      {
        "id": 81011,
        "text": "<p><span style=\"font-size:12.0pt;\">Peg IFN for 52 weeks</span></p>"
      },
      {
        "id": 81012,
        "text": "<p><span style=\"font-size:12.0pt;\">Combined peg IFN with lamivudine</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male is found to be positive for HBsAg and HBeAg and is diagnosed with chronic hepatitis B. The viral load of the patient was 2 x 10^5 IU/mL and ALT is found to be doubled. What is the appropriate management? (NEET PG 2023)</span></p>",
    "unique_key": "Q4233835",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233333,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tenofovir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is diagnosed with chronic hepatitis B, as indicated by the positive HBsAg and HBeAg, which are markers of infection and infectivity, respectively. The viral load of 2 x 10<sup>5</sup> IU/mL and elevated ALT levels suggest active viral replication and liver inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBsAg (Hepatitis B surface antigen)</strong>: This is a marker of infection. Its presence indicates that the person is infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBeAg (Hepatitis B e antigen)</strong>: This is a marker of infectivity. It indicates that the virus is replicating and the patient is highly infectious.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>HBV DNA</strong>: This is a marker of viral replication. In chronic hepatitis B, a high level of HBV DNA correlates with an increased risk of complications such as cirrhosis and hepatocellular carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The decision to start treatment in chronic hepatitis B is primarily based on the levels of HBV DNA and ALT. According to guidelines, treatment is indicated if:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBV DNA is more than 2000 IU/mL.</span></li><li><span style=\"font-size:12.0pt;\">ALT is elevated (more than 2 to 3 times the upper limit of normal).</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this patient, both criteria are met.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir</strong> is preferred for its efficacy and lower risk of resistance compared to other options like lamivudine. Tenofovir is also favored over interferon-based therapies due to better durability of response and lower side effect profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lamivudine</strong>: This drug is no longer preferred due to a high risk of resistance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Peg IFN for 52 weeks</strong>: Pegylated interferon is not preferred due to less favorable response rates and a higher side effect profile compared to tenofovir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Combined peg IFN with lamivudine</strong>: Combination therapy with pegylated interferon and lamivudine is not recommended due to increased side effects and no significant improvement in efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Tenofovir is the preferred treatment for chronic hepatitis B with high viral load and elevated ALT levels due to its efficacy and lower risk of resistance.</strong></span></p>",
    "correct_choice_id": 81010,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74888,
    "choices": [
      {
        "id": 298449,
        "text": "<p><span style=\"font-size:16px;\">Ustekinumab</span></p>"
      },
      {
        "id": 298450,
        "text": "<p><span style=\"font-size:16px;\">Etanercept</span></p>"
      },
      {
        "id": 298451,
        "text": "<p><span style=\"font-size:16px;\">Vedolizumab</span></p>"
      },
      {
        "id": 298452,
        "text": "<p><span style=\"font-size:16px;\">Tofacitinib</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which JAK inhibitor drug is recommended for moderate to severe ulcerative colitis in a patient who is not responding well to TNF-alpha blockers? (INICET NOV 2024)</span></p>",
    "unique_key": "Q4669499",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233206,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Tofacitinib</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Tofacitinib is a JAK (Janus Kinase) inhibitor that is specifically approved for treating moderate to severe ulcerative colitis in patients who have failed or are not responding to TNF-alpha blockers. It represents a different mechanism of action compared to TNF-alpha inhibitors, making it a suitable alternative for patients who have failed anti-TNF therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Ustekinumab:</strong> Incorrect. While it can be used in inflammatory bowel disease, it is a combined anti-IL-12 and IL-23 blocker, not a JAK inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Etanercept:</strong> Incorrect. This is an anti-TNF drug, and the question specifically asks about patients who are not responding to TNF-alpha blockers.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Vedolizumab:</strong> Incorrect. This is an \u03b14\u03b27 integrin blocker used in IBD, but not a JAK inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Tofacitinib is the JAK inhibitor approved for moderate to severe ulcerative colitis in patients who have failed TNF-alpha blockers. Other JAK inhibitors used in rheumatological diseases include baricitinib and upadacitinib.</span></p>",
    "correct_choice_id": 298452,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52812,
    "choices": [
      {
        "id": 210737,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ankylosing spondylitis</span></span></span></p>"
      },
      {
        "id": 210738,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paget&#39;s disease</span></span></span></p>"
      },
      {
        "id": 210739,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Healed tuberculosis</span></span></span></p>"
      },
      {
        "id": 210740,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteopetrosis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young man came to the medical OPD with complaints of early morning backache and stiffness, which improves on exercise, and persistent red eyes. On examination, lung expansion was less than 3 cm. X-ray is shown in the image given below. What is the most probable diagnosis? (NEET PG 2023)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-30-170601.jpg\" style=\"height:363px; width:276px\" /></span></span></span></p>",
    "unique_key": "Q9181986",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233369,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Ankylosing spondylitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints, leading to pain and stiffness. The hallmark feature of AS is inflammatory back pain, which is characterized by pain and stiffness that are worse in the morning and improve with exercise. The persistent red eyes are indicative of anterior uveitis, a common extra-articular manifestation of AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reduced lung expansion (less than 3 cm) points towards involvement of the thoracic spine, leading to restrictive lung disease due to reduced chest wall mobility. The X-ray image shows characteristic changes of AS, including syndesmophytes and the &quot;<strong>bamboo spine&quot; appearance</strong>, which result from the ossification of ligaments and entheses (where tendons and ligaments attach to the bone).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/31/screenshot-2024-07-31-120619.jpg\" style=\"height:475px; width:300px\" /></span></span></p>\r\n\r\n<p style=\"text-align:center\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bamboo spine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Paget&#39;s disease:</span></strong><span style=\"font-size:12.0pt\"> This condition is characterized by abnormal bone remodeling but does not typically present with inflammatory back pain or extra-articular manifestations such as uveitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Healed</span></strong><span style=\"font-size:12.0pt\"> <strong>tuberculosis:</strong> While tuberculosis can affect the spine (Pott&#39;s disease), it does not present with the classic inflammatory back pain or the characteristic radiographic changes seen in AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Osteopetrosis:</span></strong><span style=\"font-size:12.0pt\"> This is a rare genetic disorder that leads to increased bone density and brittleness but does not present with the clinical and radiographic features of AS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ankylosing spondylitis should be suspected in young patients with inflammatory back pain that improves with exercise, reduced lung expansion, and extra-articular manifestations such as uveitis. The &quot;bamboo spine&quot; on X-ray is a characteristic finding in advanced cases of AS.</span></span></p>",
    "correct_choice_id": 210737,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74905,
    "choices": [
      {
        "id": 298517,
        "text": "<p><span style=\"font-size:16px;\">Making a fist with forearm exercise</span></p>"
      },
      {
        "id": 298518,
        "text": "<p><span style=\"font-size:16px;\">Tourniquet should be tied and released as soon as possible</span></p>"
      },
      {
        "id": 298519,
        "text": "<p><span style=\"font-size:16px;\">Should be collected in sitting position &amp; better to avoid prolonged immobilization</span></p>"
      },
      {
        "id": 298520,
        "text": "<p><span style=\"font-size:16px;\">Sample should be analyzed within 15\u201330 min of collection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following should be prevented when collecting a blood sample for serum calcium? (INICET NOV 2024)</span></p>",
    "unique_key": "Q6989240",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233223,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Making a fist with forearm exercise</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Making a fist and performing forearm exercises during blood collection for calcium measurement should be prevented, as it can cause muscle ischemia and erroneously increase the calcium value in the sample. This is a practical consideration during blood collection when lab personnel often ask patients to make a fist and perform repetitive movements to better visualize veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Tourniquet should be tied and released as soon as possible:&nbsp;</strong>The tourniquet should be tied and released as soon as possible to avoid erroneously high calcium values. In some cases, for repeat calcium or PTH measurements, it's recommended to avoid tourniquet use altogether.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Should be collected in sitting position &amp; better to avoid prolonged immobilization:</strong> Collecting samples in sitting position and avoiding prolonged immobilization is recommended, as standing can increase serum calcium levels. Prolonged sitting/immobilization can also affect values due to bone lysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Sample should be analyzed within 15\u201330 min of collection:</strong> Samples should ideally be analyzed within 15\u201330 minutes of collection. If delay is anticipated, the sample should be kept on ice (good for 2 hours) or centrifuged to obtain plasma/serum (stable at room temperature for 8 hours).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Making a fist and performing forearm exercises during blood collection for calcium measurement should be avoided, as it can falsely elevate calcium levels through muscle ischemia.</span></p>",
    "correct_choice_id": 298517,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11353,
    "choices": [
      {
        "id": 45378,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antiarrhythmics</span></span></span></p>"
      },
      {
        "id": 45379,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IV NaHCO3</span></span></span></p>"
      },
      {
        "id": 45380,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Propranolol</span></span></span></p>"
      },
      {
        "id": 45381,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Phenytoin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient on antidepressants presented to you with hypotension. An ECG was done, which showed wide QRS complexes and right axis deviation. How will you manage this patient? (Neet pg 2022)</span></span></span></p>",
    "unique_key": "Q1539203",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233376,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. IV NaHCO3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with symptoms indicative of tricyclic antidepressant (TCA) overdose, which includes hypotension, wide QRS complexes, and right axis deviation on the ECG. TCAs can block sodium channels in the heart, leading to QRS widening and the potential for serious arrhythmias. They also have anticholinergic effects, which can contribute to the clinical picture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line treatment for TCA overdose, especially in the presence of cardiac toxicity such as wide QRS complexes, is intravenous sodium bicarbonate (IV NaHCO3). Sodium bicarbonate works by alkalinizing the blood, which helps to overcome the sodium channel blockade caused by TCAs. It also increases the extracellular sodium concentration, which can help stabilize cardiac cell membranes and improve conduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Antiarrhythmics</strong>: While antiarrhythmics might be considered in other cases of cardiac arrhythmias, they are not the first-line treatment for TCA overdose. In fact, some antiarrhythmic drugs can worsen the condition by further blocking sodium channels or prolonging the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Propranolol</strong>: Propranolol is a beta-blocker used to treat high blood pressure and certain types of arrhythmias. However, it is not indicated for the treatment of TCA toxicity and can potentially exacerbate hypotension and cardiac conduction abnormalities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Phenytoin</strong>: Phenytoin is an anticonvulsant that can also be used for certain types of arrhythmias. However, it is not effective in treating the sodium channel blockade caused by TCAs and is not recommended for managing TCA overdose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary treatment for tricyclic antidepressant overdose, especially when presenting with wide QRS complexes and right axis deviation, is intravenous sodium bicarbonate (IV NaHCO3).</span></span></p>",
    "correct_choice_id": 45379,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74913,
    "choices": [
      {
        "id": 298549,
        "text": "<p><span style=\"font-size:16px;\">Modified Marsh classification</span></p>"
      },
      {
        "id": 298550,
        "text": "<p><span style=\"font-size:16px;\">IgA transglutaminase positivity</span></p>"
      },
      {
        "id": 298551,
        "text": "<p><span style=\"font-size:16px;\">IgG antigliadin positivity</span></p>"
      },
      {
        "id": 298552,
        "text": "<p><span style=\"font-size:16px;\">HLA DQ6 and HLA DQ11</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not associated with celiac disease? (INICET NOV 2024)</span></p>",
    "unique_key": "Q7988841",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233324,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) HLA DQ6 and HLA DQ11</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Celiac disease is associated with specific HLA types \u2013 <strong>DQ2 (present in 95% of cases)</strong> and <strong>DQ8</strong>. HLA DQ6 and HLA DQ11 are <strong>not associated</strong> with celiac disease. The genetic predisposition to celiac disease is strongly linked to these specific HLA markers, which are essential for disease development.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Modified Marsh classification:</strong> Correct. Used for diagnosing celiac disease via endoscopic biopsies and to monitor improvement on a gluten-free diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. IgA transglutaminase positivity:</strong> Correct. Anti-tissue transglutaminase IgA (anti-tTG IgA) is the most reliable serologic test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. IgG antigliadin positivity:</strong> Correct. Although less specific, it is useful especially in IgA-deficient patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Celiac disease is genetically associated with <strong>HLA-DQ2</strong> (95% of cases) and <strong>HLA-DQ8</strong>, not HLA-DQ6 and HLA-DQ11.</span></p>",
    "correct_choice_id": 298552,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11347,
    "choices": [
      {
        "id": 45354,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. long-acting insulin</span></p>"
      },
      {
        "id": 45355,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with S.C. regular insulin</span></p>"
      },
      {
        "id": 45356,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous insulin I.V. long-acting insulin</span></p>"
      },
      {
        "id": 45357,
        "text": "<p><span style=\"font-size:12.0pt;\">Intravenous fluids with I.V. regular insulin</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient with diabetes mellitus for the past 5 years presents with vomiting and abdominal pain. She is non-compliant with medication and appears dehydrated. Investigations revealed a blood sugar value of 500 mg/dL and the presence of ketone bodies. What is the next best step in management? (Neet pg 2022)</span></p>",
    "unique_key": "Q2295940",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233370,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Intravenous fluids with I.V. regular insulin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with diabetic ketoacidosis (DKA), the immediate management involves <strong>FLIP Therapy (fluid resuscitation, insulin therapy and Potassium management)</strong>. This patient's blood glucose is significantly elevated, and the presence of ketones indicates DKA, which is a medical emergency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Fluids</strong>: The initial step is to administer intravenous (IV) fluids to correct dehydration and stabilize the patient's hemodynamic status. The typical approach involves giving isotonic saline (0.9% sodium chloride) at a <strong>rate of 10-20 mL/kg/hr (2-3L) for the first 2-3 hours</strong>. This helps to correct hypovolemia, improve perfusion, and begin to lower blood glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for fluid management</strong>: After the initial two to three hours of treatment, switch from initial fluids (typically normal saline) to half normal saline for ongoing maintenance.&nbsp;If capillary blood glucose (CBG) drops below 300 mg/dL, and specifically if it falls below 250 mg/dL, add 5% dextrose water to the regimen.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">The purpose of adding dextrose is to maintain a target CBG range of 200 to 300 mg/dL. This range helps prevent hypoglycemia, which is a critical concern in the management process.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Insulin</strong>: Insulin therapy is crucial to halt ketogenesis and reduce blood glucose levels. After 1 hr of fluid start insulin. The <strong>recommended protocol for DKA involves IV regular insulin</strong> because of its rapid onset and short duration of action. The insulin regimen follows a fixed dose insulin infusion (FDII) approach. This helps to normalize blood glucose and ketone levels efficiently.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">First option: Continuous infusion at 0.15 units/kg/hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Second option (<strong>more commonly used</strong>): Administer a 0.1 units/kg bolus, followed by a 0.1 units/kg/hour infusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IV regular insulin</strong> is preferred over subcutaneous (SC) insulin in emergency settings like DKA due to its predictable absorption and ability to be titrated easily based on frequent blood glucose monitoring.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adjustments Based on Blood Glucose Levels</strong>: Monitor capillary blood glucose (CBG). If CBG drops below 300 mg/dL, reduce the insulin infusion to half the dose (0.05 units/kg/hour).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for Stopping Insulin Infusion</strong>: Insulin infusion can be stopped ONLY when the patient tolerates oral feeds without vomiting or abdominal pain. Other criteria include resolution of ketoacidosis, negative or trace positive plasma ketones, and an <strong>anion gap less than 12</strong>, pH more than 7.3 and serum bicarbonate more than 18.</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Transition to subcutaneous insulin upon meeting these criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Potassium</strong> Management: Potassium addition is tailored based on serum potassium levels. When serum potassium levels are within a normal range, add approximately 40 milliequivalents of potassium chloride (KCL) per liter of IV fluid administered. This ensures adequate potassium levels to prevent hypokalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Monitoring</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">If serum potassium is below 3.3, administer IV potassium chloride (KCL) before insulin to prevent hypokalemia-induced arrhythmias.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium is between 3.3 and 5.2, administer insulin and KCL together.</span></li><li><span style=\"font-size:12.0pt;\">If serum potassium exceeds 5.3 &amp; above, administer insulin without KCL and monitor serum potassium closely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment Goals and Precautions</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Aim for a target CBG of 200 to 300 mg/dL to avoid hypoglycemia.</span></li><li><span style=\"font-size:12.0pt;\">The common causes of death in patients with DKA, particularly during the treatment phase \u2013&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Cerebral edema</strong> (MC) may occur due to a rapid decrease in blood glucose levels, which can lead to an osmotic shift. This shift causes fluids to move from the extracellular fluid (ECF) to the intracellular fluid (ICF), resulting in swelling of the brain tissue.</span></li><li><span style=\"font-size:12.0pt;\">2<sup>nd</sup> MC cause is <strong>Potassium Disorder</strong> esp. Hypokalemia, this can result in ventricular arrythmias.</span></li><li><span style=\"font-size:12.0pt;\">Other causes include ARDS, patients can initially develop acute kidney injury (pre-renal), later if severe, leads to ATN (Acute tubular necrosis) due to hypoperfusion of kidneys.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Intravenous fluids with S.C. long-acting insulin</strong>: Long-acting insulin is not suitable for acute management due to its prolonged action and delayed onset, making it inappropriate for rapid correction of hyperglycemia and ketonemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Intravenous fluids with S.C. regular insulin</strong>: While regular insulin is appropriate, the subcutaneous route is less effective in severe DKA where IV administration allows for better control and titration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Intravenous insulin I.V. long-acting insulin</strong>: Long-acting insulin is never administered IV due to the risk of prolonged hypoglycemia and lack of titratability. It is also not designed for acute management settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of diabetic ketoacidosis (DKA), the initial steps involve aggressive IV fluid resuscitation followed by IV regular insulin to rapidly lower blood glucose and resolve ketosis.</span></p>",
    "correct_choice_id": 45357,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50968,
    "choices": [
      {
        "id": 203413,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyper-ketonemia&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203414,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased Amino acids&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203415,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Raised glucose&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203416,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased fatty acid synthesis&nbsp;</span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old lady with diabetes mellitus comes with dizziness. Which of the following would be seen in a patient with hyperinsulinemia?</span></span></p>",
    "unique_key": "Q7231133",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233191,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased fatty acid synthesis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperinsulinemia refers to an elevated level of insulin in the blood. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin is a lipogenic hormone, meaning it promotes the synthesis of fatty acids and their storage as triglycerides in adipose tissue. This is due to insulin&#39;s ability to activate enzymes involved in lipogenesis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hyper-ketonemia:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect. Insulin suppresses ketone production, so hyperinsulinemia would prevent the formation of ketone bodies.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased Amino acids:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect. Insulin promotes protein synthesis and reduces the level of amino acids in the blood by enhancing their uptake into cells and their incorporation into proteins.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; </span></span></span></span></p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Raised glucose:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect. Hyperinsulinemia lowers blood glucose levels by promoting glucose uptake into cells and inhibiting gluconeogenesis and glycogenolysis in the liver.</span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperinsulinemia promotes increased fatty acid synthesis due to insulin&#39;s role as a lipogenic hormone, which enhances the storage of energy in the form of fat.</span></span></p>",
    "correct_choice_id": 203416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74875,
    "choices": [
      {
        "id": 298401,
        "text": "<p><span style=\"font-size:16px;\">Encephalitis</span></p>"
      },
      {
        "id": 298402,
        "text": "<p><span style=\"font-size:16px;\">Acute severe ulcerative colitis</span></p>"
      },
      {
        "id": 298403,
        "text": "<p><span style=\"font-size:16px;\">ARDS</span></p>"
      },
      {
        "id": 298404,
        "text": "<p><span style=\"font-size:16px;\">Acute pancreatitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">The Truelove and Witt criteria are used for assessing which of the following conditions? (INICET NOV 2024)</span></p>",
    "unique_key": "Q5762798",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233194,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Acute severe ulcerative colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The Truelove and Witt criteria are specifically used for assessing the severity of ulcerative colitis. These criteria help classify the disease into mild, moderate, or severe categories.</span></p><p><br><span style=\"font-size:16px;\">Another set of criteria called the Travis criteria is used to assess treatment response and predict the risk of progression to surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Encephalitis:</strong> Incorrect because encephalitis has its own specific diagnostic criteria and severity assessment tools that focus on neurological symptoms and findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. ARDS:</strong> Incorrect because ARDS is diagnosed and classified using the Berlin criteria (2012), which primarily use the P/F ratio (PaO2/FiO2) with a PEEP of at least 5 cm H2O.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Acute pancreatitis:</strong> Incorrect because acute pancreatitis has scoring systems for severity assessment, such as Ranson's criteria or the APACHE II score.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Truelove and Witt criteria are used for assessing the severity of ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Truelove and Witt's Criteria for Severity of Ulcerative Colitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TjxPFrg.png\" width=\"759\" height=\"348\"></strong></span></p>",
    "correct_choice_id": 298402,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20256,
    "choices": [
      {
        "id": 80985,
        "text": "<p><span style=\"font-size:12.0pt;\">Bumetanide</span></p>"
      },
      {
        "id": 80986,
        "text": "<p><span style=\"font-size:12.0pt;\">Ethacrynic acid</span></p>"
      },
      {
        "id": 80987,
        "text": "<p><span style=\"font-size:12.0pt;\">Nesiritide</span></p>"
      },
      {
        "id": 80988,
        "text": "<p><span style=\"font-size:12.0pt;\">Mannitol</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient with hyperkalemia and elevated urea levels underwent dialysis. Towards the end of the session, she became drowsy and had a sudden seizure episode. On examination, the patient was hypotensive. What is the treatment for this condition? (NEET PG 2023)</span></p>",
    "unique_key": "Q1882201",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233330,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D. Mannitol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient is experiencing <strong>Dialysis Disequilibrium Syndrome (DDS</strong>), a complication that can occur during or after hemodialysis, especially in patients with <strong>initially very high urea levels</strong> undergoing dialysis for the first time. DDS is caused by a rapid decrease in urea levels in the blood, leading to a sudden change in osmolarity, which causes water to move into the cells, resulting in cerebral edema and neurological symptoms such as drowsiness and seizures.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Dialysis Disequilibrium Syndrome (DDS):</strong> This condition is characterized by neurological symptoms due to cerebral edema caused by rapid changes in blood urea levels during dialysis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mannitol:</strong> This osmotic diuretic is used to treat cerebral edema by reducing intracranial pressure and drawing fluid out of the brain cells, thus decreasing cerebral edema.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bumetanide:</strong> This loop diuretic is used for fluid overload but not specifically indicated for treating cerebral edema in DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ethacrynic acid:</strong> Another loop diuretic, similar to bumetanide, and not used for DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nesiritide:</strong> A recombinant form of B-type natriuretic peptide used in acute heart failure, not for treating DDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment for Dialysis Disequilibrium Syndrome (DDS), which can occur during or after dialysis, involves reducing cerebral edema. The first-line treatment is mannitol, an osmotic diuretic.</span></p>",
    "correct_choice_id": 80988,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20253,
    "choices": [
      {
        "id": 80973,
        "text": "<p><span style=\"font-size:12.0pt;\">Spironolactone</span></p>"
      },
      {
        "id": 80974,
        "text": "<p><span style=\"font-size:12.0pt;\">Hydrochlorothiazide</span></p>"
      },
      {
        "id": 80975,
        "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
      },
      {
        "id": 80976,
        "text": "<p><span style=\"font-size:12.0pt;\">Prazosin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient is a known case of hypertension and is on multiple antihypertensive drugs. His ECG is shown below. Which drug is responsible for the following ECG? (NEET PG 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/30/screenshot-2024-07-30-143631.jpg\" alt=\"\" width=\"500\" height=\"259\"></span></p>",
    "unique_key": "Q9140673",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233328,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A. Spironolactone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG shows tall, tented T waves, absent P waves (atrial standstill), and a severely widened QRS complex. These are classic signs of severe hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spironolactone&nbsp;</strong>is a potassium-sparing diuretic that can cause hyperkalemia. It is known for increasing potassium levels in the blood by inhibiting the effects of aldosterone, leading to decreased excretion of potassium in the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the drug most likely responsible for the ECG findings is Spironolactone due to its potent potassium-sparing effects leading to severe hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hydrochlorothiazide</strong>: Causes hypokalemia, not hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metoprolol:</strong> Can cause mild hyperkalemia but not to the extent seen in the ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prazosin:</strong> Does not affect potassium levels significantly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Spironolactone, a potassium-sparing diuretic, can cause severe hyperkalemia, which is characterized by tall, tented T waves, absent P waves, and widened QRS complexes on an ECG.</span></p>",
    "correct_choice_id": 80973,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 20274,
    "choices": [
      {
        "id": 81057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pseudogout</span></span></span></p>"
      },
      {
        "id": 81058,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute gout</span></span></span></p>"
      },
      {
        "id": 81059,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reactive arthritis</span></span></span></p>"
      },
      {
        "id": 81060,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Septic arthritis</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A chronic alcoholic patient presents with acute pain and swelling of the left great toe. There is no history of trauma. Synovial fluid analysis shows raised leukocytes. Lab investigations show normal serum uric acid levels. What is the most likely diagnosis? (NEET PG 2023)</span></span></span></p>",
    "unique_key": "Q2994041",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233364,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Acute gout</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with acute pain and swelling in the left great toe, a common presentation of acute gout. Despite normal serum uric acid levels, the clinical presentation and the findings from the synovial fluid analysis point towards acute gout.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Key Findings:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Pain and Swelling of the Left Great Toe:</span></strong><span style=\"font-size:12.0pt\"> This is characteristic of acute gout, especially involving the first metatarsophalangeal (MTP) joint.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">No History of Trauma:</span></strong><span style=\"font-size:12.0pt\"> This excludes traumatic causes of joint pain.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Synovial Fluid Analysis Shows Raised Leukocytes:</span></strong><span style=\"font-size:12.0pt\"> Indicates an inflammatory arthritis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Normal Serum Uric Acid Levels:</span></strong><span style=\"font-size:12.0pt\"> In 30-40% of acute gout cases, serum uric acid levels can be normal due to the uric acid being sequestered in the joint rather than in the bloodstream.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Acute Gout&nbsp;</span></strong><span style=\"font-size:12.0pt\">is a form of inflammatory arthritis caused by the deposition of monosodium urate crystals in joints, leading to intense pain and swelling. The first MTP joint is the most commonly affected site. Acute gout can present with normal serum uric acid levels, particularly during an acute attack, due to the uric acid being sequestered in the joint.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis Confirmation:</span></strong><span style=\"font-size:12.0pt\"> The diagnosis of gout is confirmed by joint aspiration and identification of negatively birefringent needle-shaped crystals under polarized light microscopy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pseudogout:</span></strong><span style=\"font-size:12.0pt\"> This condition usually presents in <strong>elderly individuals</strong> and often involves the knee or wrist joints. The presence of <strong>chondrocalcinosis on X-ray</strong> and the involvement of joints like knee (MC), wrist or MCP joint (NOT first MTP joint) makes pseudogout less likely in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Reactive Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically follows a gastrointestinal or genitourinary infection and involves multiple joints. There is no mention of such a history in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Septic Arthritis:</span></strong><span style=\"font-size:12.0pt\"> This condition is usually associated with more severe systemic symptoms like fever and a more aggressive clinical course. The patient&#39;s presentation does not match the typical features of septic arthritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educaitonal Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute gout can present with normal serum uric acid levels, especially during an acute attack, and the involvement of the first metatarsophalangeal (MTP) joint is highly characteristic of this condition.</span></span></p>",
    "correct_choice_id": 81058,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74911,
    "choices": [
      {
        "id": 298541,
        "text": "<p><span style=\"font-size:16px;\">Protein C deficiency</span></p>"
      },
      {
        "id": 298542,
        "text": "<p><span style=\"font-size:16px;\">Prothrombin deficiency</span></p>"
      },
      {
        "id": 298543,
        "text": "<p><span style=\"font-size:16px;\">Factor V Leiden mutation</span></p>"
      },
      {
        "id": 298544,
        "text": "<p><span style=\"font-size:16px;\">Antithrombin III Deficiency</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">What is the most common cause of inherited Thrombophilia? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8567603",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233322,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Factor V Leiden mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Factor V Leiden mutation is the <strong>most common inherited cause</strong> of thrombophilia. This genetic mutation makes <strong>Factor V resistant to inactivation by activated Protein C</strong>, leading to increased thrombotic risk. It is an autosomal dominant disorder and is particularly common in individuals of European descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Protein C deficiency:</strong> Less common than Factor V Leiden; leads to increased thrombotic risk</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Prothrombin deficiency:</strong> A rare inherited coagulation disorder that typically causes bleeding</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Antithrombin III deficiency:</strong> Relatively rare inherited thrombophilic condition</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Factor V Leiden mutation</strong> is the most common inherited cause of thrombophilia.</span></p>",
    "correct_choice_id": 298543,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74902,
    "choices": [
      {
        "id": 298505,
        "text": "<p><span style=\"font-size:16px;\">Smoking</span></p>"
      },
      {
        "id": 298506,
        "text": "<p><span style=\"font-size:16px;\">Standing posture</span></p>"
      },
      {
        "id": 298507,
        "text": "<p><span style=\"font-size:16px;\">Hyperglycemia</span></p>"
      },
      {
        "id": 298508,
        "text": "<p><span style=\"font-size:16px;\">Exercise</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not a stimulus for catecholamine synthesis? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2963376",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233220,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Hyperglycemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hyperglycemia is not a stimulus for catecholamine synthesis. Physiologically, hyperglycemia can suppress catecholamine synthesis. While hyperglycemic emergencies may indirectly lead to increased catecholamines due to shock and osmotic diuresis, hyperglycemia itself does not directly stimulate catecholamine production. Hypoglycemia (not hyperglycemia) is a potent stimulus for catecholamine release, leading to autonomic symptoms like tremors, palpitations, anxiety, and sweating.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Smoking:</strong> Incorrect. Smoking is a known stimulus for catecholamine synthesis. Nicotine triggers the release of catecholamines from the adrenal medulla and sympathetic nerve endings.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Standing posture:</strong> Incorrect. Orthostatic changes require a catecholamine surge to prevent orthostatic hypotension when a person stands up. This is a normal physiological response.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Exercise:</strong> Incorrect. Exercise is one of the major physiological stimuli for catecholamine synthesis. Physical activity requires increased sympathetic activation and catecholamine production.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Hypoglycemia (not hyperglycemia) is a potent stimulus for catecholamine release, leading to autonomic symptoms like tremors, palpitations, anxiety, and sweating. Hyperglycemia does not stimulate catecholamine synthesis.</span></p>",
    "correct_choice_id": 298507,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74894,
    "choices": [
      {
        "id": 298473,
        "text": "<p><span style=\"font-size:16px;\">Hypoparathyroidism is common</span></p>"
      },
      {
        "id": 298474,
        "text": "<p><span style=\"font-size:16px;\">Type 1 Diabetes Mellitus association is high</span></p>"
      },
      {
        "id": 298475,
        "text": "<p><span style=\"font-size:16px;\">Association with mucocutaneous candidiasis is high</span></p>"
      },
      {
        "id": 298476,
        "text": "<p><span style=\"font-size:16px;\">Early onset in infancy</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">Which of the following is not typically associated with Autoimmune Polyendocrine Syndrome Type 1 (APS-1)? (INICET NOV 2024)</span></p>",
    "unique_key": "Q8150158",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233212,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Type 1 Diabetes Mellitus association is high</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Type 1 Diabetes Mellitus does not have a high association with APS-1. The association is low and not a characteristic feature of APS-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hypoparathyroidism is common:</strong> Hypoparathyroidism is common and is part of the classic triad of APS-1.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Association with mucocutaneous candidiasis is high:</strong> Mucocutaneous candidiasis is highly associated with APS-1. It is typically the first manifestation, appearing in infancy, and is also the most common manifestation due to underlying immunodeficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Early onset in infancy:</strong> Early onset in infancy is characteristic of APS-1, with mucocutaneous candidiasis typically being the first manifestation to appear.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Classic triad of APS-1:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Mucocutaneous candidiasis (most common and earliest manifestation)</span></li><li><span style=\"font-size:16px;\">Hypoparathyroidism</span></li><li><span style=\"font-size:16px;\">Addison's disease</span></li></ol>",
    "correct_choice_id": 298474,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 52811,
    "choices": [
      {
        "id": 210733,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic stenosis</span></span></span></p>"
      },
      {
        "id": 210734,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Aortic regurgitation</span></span></span></p>"
      },
      {
        "id": 210735,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral regurgitation</span></span></span></p>"
      },
      {
        "id": 210736,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tricuspid regurgitation</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male patient presented to the hospital with palpitations. Physical examination showed a diastolic murmur in the left 3rd intercostal space. What is the most likely diagnosis? (NEET PG 2023)</span></span></p>",
    "unique_key": "Q8694801",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233368,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Aortic regurgitation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presence of a diastolic murmur heard best at the left 3rd intercostal space (Erb&#39;s point) is characteristic of aortic regurgitation. Aortic regurgitation occurs when the aortic valve does not close properly, allowing blood to flow back into the left ventricle during diastole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aortic stenosis:</span></strong><span style=\"font-size:12.0pt\"> This condition produces a systolic ejection murmur, typically heard at the right second intercostal space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Mitral regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This condition causes a pansystolic murmur heard best at the apex of the heart and radiates to the axilla.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Tricuspid regurgitation:</span></strong><span style=\"font-size:12.0pt\"> This condition causes a pansystolic murmur heard best at the lower left sternal border.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aortic Regurgitation&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is associated with a diastolic murmur, best heard at Erb&rsquo;s point (left 3rd intercostal space). The murmur is typically described as a high-pitched, blowing, decrescendo murmur.</span></span></p>",
    "correct_choice_id": 210734,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "RecentNEETPG"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74891,
    "choices": [
      {
        "id": 298461,
        "text": "<p><span style=\"font-size:16px;\">1, 2</span></p>"
      },
      {
        "id": 298462,
        "text": "<p><span style=\"font-size:16px;\">1, 2, 3</span></p>"
      },
      {
        "id": 298463,
        "text": "<p><span style=\"font-size:16px;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 298464,
        "text": "<p><span style=\"font-size:16px;\">1, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">LMN lesions are associated with? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Decrease in muscle tone</span></li><li><span style=\"font-size:16px;\">Spastic paralysis</span></li><li><span style=\"font-size:16px;\">Babinski positivity</span></li><li><span style=\"font-size:16px;\">Fasciculations</span></li></ol>",
    "unique_key": "Q5346313",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233209,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.</strong> <strong>D) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Lower motor neuron (LMN) lesions are characterized by two features:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">1. <strong>Decreased in muscle tone (flaccidity)</strong> \u2013 Due to interruption of the normal reflex arc</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">4. <strong>Fasciculations</strong> \u2013 Spontaneous twitching of muscle fibers due to denervation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">2. <strong>Spastic paralysis</strong> is a characteristic of upper motor neuron (UMN) lesions</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">3. <strong>Babinski positivity</strong> sign (upgoing plantar response) is also a feature of UMN lesions</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These features occur due to loss of inhibitory signals from upper motor neurons, which is not the case in LMN lesions</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Lower motor neuron lesions are characterized by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Decreased muscle tone (flaccidity)</span></li><li><span style=\"font-size:16px;\">Fasciculations (muscle twitching)</span></li><li><span style=\"font-size:16px;\">Absence of spasticity and Babinski sign (which are UMN signs)</span></li></ol>",
    "correct_choice_id": 298464,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50970,
    "choices": [
      {
        "id": 203421,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">At least 80g dietary fibre&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203422,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;5 g salt intake everyday&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203423,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt; 30% of the calories should come from fat&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203424,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol &lt; 100g&nbsp;</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A diabetic patient&#39;s fasting blood glucose level is found to be 160 mg/dL. What will you advise the patient regarding non-pharmacological management? (</span></span>INICET Nov 2023)</p>",
    "unique_key": "Q1297248",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233193,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) &lt; 30% of the calories should come from fat</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When advising a diabetic patient on non-pharmacological management, it is essential to focus on dietary and lifestyle modifications that can help control blood glucose levels and reduce cardiovascular risk. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is advisable for less than 30% of daily caloric intake to come from fat, with saturated fat being less than 10% and avoiding trans fats altogether. This recommendation helps in managing cholesterol levels and reducing cardiovascular risk.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>At least 80g dietary fibre:</strong> The recommended daily intake of dietary fiber is 25 to 40 grams, not 80 grams. High fiber intake helps in controlling blood sugar levels.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>&lt;5 g salt intake everyday</strong>: The recommendation for sodium intake is less than 2.3 grams per day, with overall salt intake being less than 5 grams per day.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; &nbsp;&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cholesterol &lt; 100g:</strong> There is no guideline recommending cholesterol intake to be less than 100 grams. Current guidelines focus more on overall fat intake and the types of fats consumed rather than specific cholesterol limits.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For diabetic patients, it is recommended that less than 30% of daily calories come from fat, with saturated fat being less than 10% and trans fats being avoided. This helps in managing blood sugar levels and reducing cardiovascular risks.</span></span></p>",
    "correct_choice_id": 203423,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 50969,
    "choices": [
      {
        "id": 203417,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203418,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primary hyperparathyroidism&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203419,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin D toxicity&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 203420,
        "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Familial hypocalciuric hypercalcemia&nbsp;</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common cause of hypercalcemia in hospitalized patients is (</span></span>INICET Nov 2023</p>",
    "unique_key": "Q4274848",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233192,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malignancy</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hospitalized patients, the most common cause of hypercalcemia is malignancy. Malignancy-associated hypercalcemia often results from the secretion of parathyroid hormone-related peptide (PTHrP) by cancer cells, which mimics the effects of parathyroid hormone, leading to increased calcium levels. This is frequently seen in cancers such as breast cancer, lung cancer, and multiple myeloma.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Primary hyperparathyroidism:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the most common cause of hypercalcemia in outpatients but not in hospitalized patients. It is characterized by elevated levels of parathyroid hormone (PTH) due to parathyroid gland hyperplasia, adenoma, or carcinoma.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Vitamin D toxicity:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypercalcemia can occur due to excessive intake of vitamin D, leading to increased intestinal absorption of calcium. However, it is not the most common cause in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Familial hypocalciuric hypercalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a rare genetic condition characterized by benign hypercalcemia with low urinary calcium excretion. It mimics primary hyperparathyroidism but is less common and typically not seen as the most frequent cause of hypercalcemia in hospitalized patients.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignancy is the most common cause of hypercalcemia in hospitalized patients, often due to the secretion of PTHrP by cancer cells.</span></span></span></span></p>",
    "correct_choice_id": 203417,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74882,
    "choices": [
      {
        "id": 298429,
        "text": "<p><span style=\"font-size:16px;\">Coagulopathy</span></p>"
      },
      {
        "id": 298430,
        "text": "<p><span style=\"font-size:16px;\">Hearing loss</span></p>"
      },
      {
        "id": 298431,
        "text": "<p><span style=\"font-size:16px;\">Haemodilution</span></p>"
      },
      {
        "id": 298432,
        "text": "<p><span style=\"font-size:16px;\">Visual loss</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">A scuba diver surfaces rapidly, soon experiencing joint pain, dizziness, and difficulty breathing indicating decompression sickness. Which of the following is not associated with it? (INICET NOV 2024)</span></p>",
    "unique_key": "Q2271724",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233201,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Haemodilution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness (DCS), or Caisson disease, occurs due to rapid ascent during diving, based on Henry's law. When pressure decreases rapidly, dissolved gases (particularly nitrogen) form bubbles in blood and tissues. These bubbles can cause vascular occlusions, organ damage, and various systemic manifestations including hemoconcentration\u2014not haemodilution.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Coagulopathy:</strong> Incorrect. Coagulopathy can occur in DCS due to endothelial damage from gas bubbles, causing a DIC-like picture in 2\u20133% of cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Hearing loss:</strong> Incorrect. Hearing loss, though rare, is a possible manifestation of DCS due to inner ear involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Visual loss:</strong> Incorrect. Visual disturbances and loss can occur in DCS due to bubble formation affecting the visual pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Decompression sickness leads to hemoconcentration (not haemodilution) and can present with joint pain (\"the bends\"), neurological symptoms, coagulopathy, and sensory organ dysfunction including vision and hearing loss.</span></p>",
    "correct_choice_id": 298431,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 74912,
    "choices": [
      {
        "id": 298545,
        "text": "<p><span style=\"font-size:16px;\">1, 3</span></p>"
      },
      {
        "id": 298546,
        "text": "<p><span style=\"font-size:16px;\">1, 4</span></p>"
      },
      {
        "id": 298547,
        "text": "<p><span style=\"font-size:16px;\">2, 3</span></p>"
      },
      {
        "id": 298548,
        "text": "<p><span style=\"font-size:16px;\">1, 2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:16px;\">In haemolytic anaemia, which of the following is correct? (INICET NOV 2024)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\">Urobilinogen is high</span></li><li><span style=\"font-size:16px;\">Serum conjugated bilirubin is elevated</span></li><li><span style=\"font-size:16px;\">Serum transaminases are increased</span></li><li><span style=\"font-size:16px;\">Indirect van den Bergh reaction is positive</span></li></ol>",
    "unique_key": "Q9460911",
    "question_audio": null,
    "question_video": null,
    "map_id": 35233323,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">In haemolytic anaemia, there is increased destruction of red blood cells leading to elevated <strong>unconjugated (indirect) bilirubin</strong>. This results in:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>1. Urobilinogen is high:</strong> Increased <strong>urobilinogen</strong> in urine due to normal enterohepatic circulation</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>4. Indirect van den Bergh reaction is positive:&nbsp;</strong>Positive indirect van den Bergh reaction due to elevated unconjugated bilirubin</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">These findings are characteristic of haemolytic anaemia and help differentiate it from other causes of jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>2. Serum conjugated bilirubin is elevated:</strong> Incorrect, as conjugated bilirubin elevation is typically seen in obstructive jaundice or hepatic diseases, not in haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>3. Serum transaminases are increased:</strong> Incorrect, as elevated transaminases indicate liver cell damage, which is not a feature of haemolytic anaemia</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Haemolytic anaemia is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Increased urobilinogen in urine</span></li><li><span style=\"font-size:16px;\">Elevated unconjugated (indirect) bilirubin</span></li><li><span style=\"font-size:16px;\">Positive indirect van den Bergh reaction</span></li><li><span style=\"font-size:16px;\">Normal enterohepatic circulation</span></li></ul>",
    "correct_choice_id": 298546,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Medicine-4)';
        const quizFilename = 'late-night-pyq-inicet-medicine-4-a3661b6f.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Night PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on navigation
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>